{"count":52,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+3267&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/42566dc4-ba29-4e41-a15b-7bedf724237f/","filing_uuid":"42566dc4-ba29-4e41-a15b-7bedf724237f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/42566dc4-ba29-4e41-a15b-7bedf724237f/print/","filing_document_content_type":"text/html","income":null,"expenses":"200000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"DAVID WIERMANSKI","dt_posted":"2026-04-02T15:12:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street, NW","registrant_address_2":"SUITE 500","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":17933,"url":"https://lda.gov/api/v1/registrants/17933/","house_registrant_id":31263,"name":"HEALTHCARE LEADERSHIP COUNCIL","description":null,"address_1":"750 9th Street, NW","address_2":"SUITE 500","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID WIERMANSKI","contact_telephone":"","dt_updated":"2026-07-14T08:39:44.484618-04:00"},"client":{"id":123360,"url":"https://lda.gov/api/v1/clients/123360/","client_id":12,"name":"HEALTHCARE LEADERSHIP COUNCIL","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-08"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 4464/ S. 3204, Preventive Health Savings Act H.R. 5145, S. 3385, Bipartisan Premium Tax Credit Extension Act H.R. 5283/S. 2759, Healthcare Workforce Resilience Act S. 2824, A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits. U.S. Department of Education Negotiated Rulemaking Committees [Docket ID ED-2025-OPE-0151-0001] U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) U.S Department of Health and Human Services, Centers for Medicare & Medicaid ServicesAdvance Notice of Methodological Changes for Calendar Year (CY) 2027 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (CMS-2026-0034) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Proposed Rule (RIN 0955-AA09) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145902,"prefix":null,"prefix_display":null,"first_name":"MARIA","nickname":null,"middle_name":null,"last_name":"GHAZAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145905,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145906,"prefix":null,"prefix_display":null,"first_name":"CLARA","nickname":null,"middle_name":null,"last_name":"KEANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147562,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153247,"prefix":null,"prefix_display":null,"first_name":"ANGELA","nickname":null,"middle_name":null,"last_name":"BANKS DUNCAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act H.R. 4093, S. 3848, Apples to Apples Comparison Act H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act H.R. 6010/S. 1105, No UPCODE Act H.R. 6130/ S. 3267, Alzheimers Screening and Prevention Act U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) U.S Department of Health and Human Services, Centers for Medicare & Medicaid ServicesAdvance Notice of Methodological Changes for Calendar Year (CY) 2027 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (CMS-2026-0034) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Proposed Rule (RIN 0955-AA09) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145902,"prefix":null,"prefix_display":null,"first_name":"MARIA","nickname":null,"middle_name":null,"last_name":"GHAZAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145905,"prefix":null,"prefix_display":null,"first_name":"COREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145906,"prefix":null,"prefix_display":null,"first_name":"CLARA","nickname":null,"middle_name":null,"last_name":"KEANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147562,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153247,"prefix":null,"prefix_display":null,"first_name":"ANGELA","nickname":null,"middle_name":null,"last_name":"BANKS DUNCAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e00c4483-52f0-44d5-abb7-5c8ace4762a2/","filing_uuid":"e00c4483-52f0-44d5-abb7-5c8ace4762a2","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e00c4483-52f0-44d5-abb7-5c8ace4762a2/print/","filing_document_content_type":"text/html","income":null,"expenses":"310000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kata Sybenga","dt_posted":"2026-04-13T11:28:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 K Street, NW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":28708,"url":"https://lda.gov/api/v1/registrants/28708/","house_registrant_id":31081,"name":"NATIONAL TREASURY EMPLOYEES UNION","description":null,"address_1":"800 K Street, NW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATA SYBENGA","contact_telephone":"+1 202-572-5500","dt_updated":"2026-07-31T11:15:48.152132-04:00"},"client":{"id":134581,"url":"https://lda.gov/api/v1/clients/134581/","client_id":12,"name":"NATIONAL TREASURY EMPLOYEES UNION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-09"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Draft Senate FY 2026 Homeland Security Appropriations bill Draft House FY 2027 Financial Services and General Government Appropriations bill H. Con. Res. 15, Calling an Article V Convention for proposing a Fiscal Responsibility Amendment to the United States Constitution and stipulating ratification by a vote of We the People, and for other purposes. H. J. Res. 110, Proposing a balanced budget amendment to the Constitution of the United States. H. J. Res. 112, Proposing an amendment to the Constitution of the United States related to the public debt. H. J. Res. 139, Proposing an amendment to the Constitution of the United States requiring a balanced budget for the Federal Government. H.R. 182, Default Prevention Act H.R. 191, Inflation Reduction Act of 2025 H.R. 196, Family and Small Business Taxpayer Protection Act H.R. 199, Implementing DOGE Act H.R. 222, Sustainable Budget Act of 2025 H.R. 374, DIRECT Act H.R. 654, TABS Act of 2025 H.R. 814, Defund the CFPB Act S. 303, Defund the CFPB Act H.R. 1180, To repeal the Impoundment Control Act of 1974. S. 515, A bill to repeal the Impoundment Control Act of 1974. H.R. 1916, Pay Our Border Patrol and Customs Agents Act of 2025 H.R. 2050, Homeland Heroes Pay Act H.R. 3001, To advance commonsense priorities. H.R. 3141, CFPB Budget Integrity Act H.R. 3289, Fiscal Commission Act H.R. 4016, Department of Defense Appropriations Act, 2026 S. 2572, Department of Defense Appropriations Act, 2026 H.R. 4178, Enforce the Caps Act H.R. 4213, Department of Homeland Security Appropriations Act, 2026 H.R. 4229, To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller General may pursue a civil action under such Act, and for other purposes. H.R. 4273, Over-the-Counter Monograph Drug User Fee Amendments H.R. 4553, Energy and Water Development and Related Agencies Appropriations Act, 2026 S. 3293, Energy and Water Development and Related Agencies Appropriations Act, 2026 H.R. 4754, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026 S. 2431, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026 H.R. 4765, Securing our Border Act H.R. 5130, Prevent Government Shutdowns Act of 2025 S. 2721, Prevent Government Shutdowns Act of 2025 H.R. 5166, Financial Services and General Government Appropriations Act, 2026 S. 3290, Financial Services and General Government Appropriations Act, 2026 H.R. 5220, Congressional Power of the Purse Act H.R. 5260, Pay Our Border Patrol and Customs Agents Act H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 2354, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5398, Pay Our Homeland Defenders Act of 2026 H.R. 5405, Government Shutdown Prevention Act of 2025 H.R. 5438, Incentivize Savings Act H.R. 5450, Continuing Appropriations and Extensions and Other Matters Act, 2026 S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5542, End Government Shutdowns Act H.R. 5552, Eliminate Shutdowns Act H.R. 5619, Federal Firefighter Paycheck Protection Act H.R. 5628, Pay Workers What Theyve Earned Act H.R. 5801, Shutdown Fairness Act S. 3012, Shutdown Fairness Act H.R. 5802, MAGA Act H.R. 5870, Prevent Government Shutdowns Act H.R. 5893, GUARD Act H.R. 5998, To provide for the continued operation of the Hatch Act Unit of the Office of Special Counsel during a lapse in appropriations, and for other purposes. H.R. 6938, Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 H.R. 7006, Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026 H.R. 7137, Shutdown Fairness Act S. 3168, Shutdown Fairness Act H.R. 7147, Further Additional Continuing Appropriations Act, 2026 H.R. 7148, Consolidated Appropriations Act, 2026 H.R. 7295, Comprehensive Congressional Budget Act of 2026 H.R. 7322, True Shutdown Fairness Act H.R. 7481, Department of Homeland Security Appropriations Act, 2026 H.R. 7617, To provide funding for administrative expenses of the Department of Homeland Security during any lapse in appropriations during fiscal year 2026, to require that the Department be responsive to congressional offices during such a lapse in appropriations, and for other purposes. H.R. 7744, Department of Homeland Security Appropriations Act, 2026 H.R. 7844, To provide the Secretary of Homeland Security with the authority to transfer funds between accounts under the Department of Homeland Security during a lapse in appropriations, and for other purposes. H.R. 8029, Pay Our Homeland Defenders Act S. J. Res. 97, A joint resolution proposing a balanced budget amendment to the Constitution of the United States. S. Res. 654, A resolution expressing the sense of the Senate that the United States should reduce and maintain the Federal unified budget deficit at or below 3 percent of gross domestic product. S. 175, A bill to rescind unobligated balances appropriated for the IRS and use for an External Revenue Service S. 181, A bill to require agencies submit zero-based budgets. S. 360, To provide for across the board rescissions of non-security discretionary spending S. 481, Securing our Border Act S. 2806, Eliminate Shutdowns Act S. 3001, Shutdown Fairness Act S. 3039, True Shutdown Fairness Act S. 3165, True Shutdown Fairness Act S. 3043, Military and Federal Employee Protection Act S. 3066, Pay the People Act S. 3681, Keep Our Border Agents Paid Act S. 3951, Balanced Budget Responsibility Act of 2026 S. 4012, Fiscal Commission Act S. 4173, Dollar-for-Dollar Deficit Reduction Act S. 4174, A bill to provide a premium payment to employees who worked without receiving pay during the shutdown of the Department of Homeland Security of 10 percent of the pay the employees should have received during the shutdown.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33834,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"VORNDRAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":3778,"prefix":null,"prefix_display":null,"first_name":"REGINA","nickname":null,"middle_name":null,"last_name":"HUTTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45731,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOCKNAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138404,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOWARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65769,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TYREE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71319,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":"C","last_name":"SYBENGA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148450,"prefix":null,"prefix_display":null,"first_name":"MARAM","nickname":null,"middle_name":null,"last_name":"ABDELHAMID","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":45,"name":"Commodity Futures Trading Commission (CFTC)"},{"id":255,"name":"Consumer Financial Protection Bureau (CFPB)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":81,"name":"Office of Personnel Management (OPM)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":184,"name":"U.S. Customs & Border Protection"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"H. Res. 186, Of inquiry requesting the President to transmit certain documents to the House of Representatives relating to the conflicts of interest of Elon Musk and related information. H. Res. 187, Of inquiry requesting the President to transmit certain information to the House of Representatives referring to the termination, removal, placement on administrative leave, moved to another department of Federal employees and Inspectors General of agencies. H. Res. 259, Of inquiry requesting the President to provide certain documents in the President's possession to the House of Representatives relating to the access provided to the staff and advisers of, including any individual working for or in conjunction with, the Department of Government Efficiency to the systems, applications, and accounts, and any information contained therein, of the Bureau of Consumer Financial Protection. H. Res. 286, Of inquiry requesting the President to transmit certain documents relating to the dangerous, unaccountable use of AI by the United States DOGE Service to jeopardize the private information and essential services of the American people. H. Res. 302, Of inquiry requesting the President and directing the Secretaries of the Treasury and Labor to transmit, respectively, certain documents to the House of Representatives relating to the effect on local economies and communities of the Department of Government Efficiency and newly-imposed tariffs. H. Res. 807, Of inquiry requesting the President to transmit certain information to the House of Representatives referring to the firings, dismissal, reduction in force, or withholding of pay for the period of the lapse in appropriations of furloughed employees of the United States Government. H. Res. 825, Of inquiry requesting the President to transmit certain information to the House of Representatives referring to United States Government agencies sharing certain communications with the public and Federal employees. H.R. 15, Equality Act S. 1503, Equality Act H.R. 25, Fair Tax Act of 2025 H.R. 51, Washington, D.C. Admission Act S. 51, Washington, D.C. Admission Act H.R. 107, Return to Work Act H.R. 195, CBP Relocation Act H.R. 200, Federal Freeze Act S. 357, Federal Freeze Act H.R. 201, Federal Employee Performance and Accountability Act of 2025 S. 359, Federal Employee Performance and Accountability Act of 2025 H.R. 202, Commission to Relocate the Federal Bureaucracy Act S. 353, Commission to Relocate the Federal Bureaucracy Act H.R. 236, Federal Employee Return to Work Act S. 27, Federal Employee Return to Work Act H.R. 242, MANAGER Act H.R. 357, Back to Work Act H.R. 371, No Hires for the Delinquent IRS Act H.R. 435, Direct Hire To Fight Fires H.R. 473, SHOW UP Act of 2025 S. 354, SHOW UP Act of 2025 H.R. 489, Federal Agency Sunset Commission Act of 2025 H.R. 491, Equal COLA Act S. 624, Equal COLA Act H.R. 492, Saving the Civil Service Act S. 134, Saving the Civil Service Act H.R. 493, FAIR Act S. 126,FAIR Act H.R. 514, SWAMP Act S. 22, SWAMP Act H.R. 687, MERIT Act of 2025 S. 662,MERIT Act of 2025 H.R. 697, End the Deep State Act H.R. 743, Tim's Act S. 279, Tim's Act H.R. 759, Federal Firefighters Families First Act H.R. 800, DEI to DIE Act H.R. 925, Dismantle DEI Act S. 382, Dismantle DEI Act of 2025 H.R. 977, Support Military Spouses Act H.R. 1075, Tax Administration Simplification Act H.R. 1101, Taxpayer Data Protection Act H.R. 1280, DRAIN THE SWAMP Act S. 23, DRAIN THE SWAMP Act H.R. 1294, BEST Facilitation Act S. 578, BEST Facilitation Act H.R. 1295, Reorganizing Government Act of 2025 S. 583, Reorganizing Government Act of 2025 H.R. 1460, Drain the Swamp Act of 2025 H.R. 1511, REDUCE Act H.R. 1522, Federal Retirement Fairness Act H.R. 1535, BAD DOGE ACT H.R. 1548, Leveling the Playing Field 2.0 Act S. 691, Leveling the Playing Field 2.0 Act H.R. 1569, CATCH Fentanyl Act S. 703, CATCH Fentanyl Act H.R. 1571, Bureaucratic Labor Adjustment and Downsizing Effort Act H.R. 1603, Repeal CFPB Act H.R. 1637, Protect Veteran Jobs Act S. 914, Protect Veteran Jobs Act H.R. 1807, Protecting Federal Agencies and Employees from Political Interference Act H.R. 1835, MERIT Act S. 1075, MERIT Act H.R. 1930, Border Workforce Improvement Act H.R. 1943, Wildland Firefighter Paycheck Protection Act of 2025 H.R. 1989, Protect Our Probationary Employees Act S. 918, Protect Our Probationary Employees Act H.R. 2006, DOGE Act H.R. 2207, Saving DOEs Workforce Act H.R. 2255, Federal Law Enforcement Officer Service Weapon Purchase Act H.R. 2285, DHS Basic Training Accreditation Improvement Act of 2025 H.R. 2324, Unity through Service Act of 2025 S. 1120, Unity through Service Act of 2025 H.R. 2421, Protecting Taxpayer Resources Act H.R. 2470, COST of Relocations Act S. 1171, COST of Relocations Act H.R. 2532, To prohibit certain removals of employees of the Department of Health and Human Services and sub-agencies and operating divisions thereof, and for other purposes. H.R. 2601, Delete DOGE Act H.R. 2677, 10th Amendment Restoration Act of 2025 H.R. 2737, ELON MUSK Act H.R. 2742, DOGE Accountability and Transparency Act H.R. 2743, Raise the Wage Act of 2025 S. 1332, Raise the Wage Act of 2025 H.R. 2829, SERVICE Act H.R. 2880, To provide employment protections for, and reinstatement of, certain probationary Federal career employees, and for other purposes. H.R. 2894, SEER Act of 2025 S. 1491, SEER Act 2025 H.R. 2905, Ensuring Agency Service Quality Act H.R. 2906, SERVICE Act H.R. 2921, Federal Firefighter Cancer Detection and Prevention Act of 2025 H.R. 2962, Border Airport Fairness Act of 2025 S. 677, Border Airport Fairness Act of 2025 H.R. 3046, Workers Memorial Day H.R. 3072, DOGE Codification Act of 2025 H.R. 3093, REHIRE Act H.R. 3094, PREP Act H.R. 3120, To improve the review and effectiveness of the cost of living adjustments to pay and benefits for members of the Armed Forces and civilian employees of the Department of Defense whose permanent duty station is located in the 19th Congressional District of California, and for other purposes. H.R. 3144, Honoring our K9 Heroes Act H.R. 3170, Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 3171, Reduction in Force Review Act S. 1585, Reduction in Force Review Act H.R. 3226, Law Enforcement Officers Equity Act H.R. 3267, PSLF Payment Completion Fairness Act S. 3487, PSLF Payment Completion Fairness Act H.R. 3305, LEO Fair Retirement Act of 2025 H.R. 3317, Honoring Civil Servants Killed in the Line of Duty Act S. 2078, Honoring Civil Servants Killed in the Line of Duty Act H.R. 3346, Sovereign State Environmental Quality Assurance Act H.R. 3364, Federal Retirement Thrift Investment Board Inspector General Act of 2025 H.R. 3404, FAIR Leave Act H.R. 3435, Federal Cyber Workforce Training Act of 2025 H.R. 3445, Bureau of Consumer Financial Protection Commission Act H.R. 3468, Protecting Retirement and Health Benefits for Families Act H.R. 3555, Protect our Parks Act of 2025 H.R. 3560, Veteran Wildland Firefighter Employment Act of 2025 H.R. 3733, Make DOGE Permanent Act H.R. 3853, Federal Government Reform Act of 2025 H.R. 3891, Northern Border Security and Staffing Reform Act H.R. 3965, PEARL Act S. 4079, PEARL Act H.R. 4052, Employment Abundance Act H.R. 4057, CBP Canine Home Kenneling Pilot Act H.R. 4176, No Secret Police Act of 2025 H.R. 4440, Protecting Federal Employee Rights to Personnel Files Act of 2025 H.R. 4582, To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition. H.R. 4672, To extend the break-in-service consideration for firefighter retirements, and other purposes. H.R. 4683, Securing Americas Ports of Entry Act of 2025 S. 1678, Securing America's Ports of Entry Act of 2025 H.R. 4727, To codify Executive Order 14235 relating to restoring public service loan forgiveness. H.R. 4823, Promoting Free and Fair Elections Act of 2025 H.R. 4854, Saving the Department of the Interior's Workforce Act S. 2597, Saving the Department of the Interior's Workforce Act H.R. 4893, National Guard and Reserve Student Loan Fairness Act H.R. 4907, Statistical Agency Integrity and Independence Act H.R. 4908, Time Off to Vote Act S. 2549, Time Off to Vote Act H.R. 4974, DETECT Act of 2025 H.R. 4996, FORWARD Act H.R. 5000, Cybersecurity Hiring Modernization Act H.R. 5091, To amend section 5545 of title 5, United States Code, to provide hazard pay for carrying out prescribed burns, and for other purposes. H.R. 5397, HEALING Mothers and Fathers Act S. 2418, HEALING Mothers and Fathers Act H.R. 5572, Help FEDS Act S. 2948, Help FEDS Act H.R. 5599, To prohibit the removal of Federal employees during any lapse in discretionary appropriations, and for other purposes. H.R. 5653, Trust Through Transparency Act of 2025 H.R. 5674, Emergency Relief for Federal Workers Act of 2025 S. 2966, Emergency Relief for Federal Workers Act of 2025 H.R. 5676, Stop Stealing Our Jobs Act H.R. 5679, TRUMP Act H.R. 5689, Shutdown Guidance for Financial Institutions Act S. 2995, Shutdown Guidance for Financial Institutions Act H.R. 5708, Federal Employees Civil Relief Act S. 2982, Federal Employees Civil Relief Act H.R. 5720, Federal Worker Childcare Protection Act of 2025 H.R. 5724, FAST Justice Act S. 2977, FAST Justice Act H.R. 5750, EQUALS Act of 2025 H.R. 5771, Reliable Social Security Service for Seniors Act H.R. 5810, Federal Supervisor Education Act H.R. 5816, HELP FEDs Act H.R. 5843, Shutdown Student Loans for Feds Act S. 3070, Shutdown Student Loans for Feds Act H.R. 5908, Non-Essential Workers Transparency Act S. 3005, Non-Essential Workers Transparency Act H.R. 6023, Government Shutdown Efficiency Act H.R. 6284, Strengthening Loan Forgiveness for Public Service Workers Act S. 3277, Strengthening Loan Forgiveness for Public Service Workers Act H.R. 6323, Taxpayer Protection and Preparer Proficiency Act H.R. 6330, Federal Relocation Payment Improvement Act H.R. 6371, No Robot Bosses Act H.R. 6548, DHS Suicide Prevention and Resiliency for Law Enforcement Act H.R. 6791, Strong Ports, Strong Communities Act S. 3504, Strong Ports, Strong Communities Act H.R. 6818, Part-Time Worker Bill of Rights Act S. 3547, Part-Time Worker Bill of Rights Act H.R. 6926, Federal Property Integrity Act H.R. 6929, Thrift Savings Plan Emergency Withdrawal Act of 2025 H.R. 6971, To require congressional approval of major Executive Orders and major rules, and for other purposes. H.R. 7039, SERVE Act S. 3622, SERVE Act H.R. 7067, No Violent Criminals in the Federal Workforce Act H.R. 7098, Homeland Threat Response Act H.R. 7102, Federal Workforce Civics Competency and Accountability Act H.R. 7228, Maintain Access to Vital Social Security Services Act of 2026 H.R. 7256, Federal Workforce Early Separation Incentives Act H.R. 7357, TSP Fiduciary Security Act of 2026 S. 1368, TSP Fiduciary Security Act of 2025 H.R. 7471, Give America a Raise Act H.R. 7480, FAIR Act S. 3823, FAIR Act H.R. 7505, Flexible Leave Act H.R. 7507, Fiscal Harms of Federal Firings Act S. 3844, Fiscal Harms of Federal Firing Act H.R. 7531, Healthy Families Act S. 3869, Healthy Families Act H.R. 7583, BE HEARD in the Workplace Act S. 3865, BE HEARD in the Workplace Act H.R. 7706, Federal Retirement Safety Act H.R. 7934, Settlement Agreement Information Database Act of 2026 H.R. 7971, Taxpayer Experience Improvement Act H.R. 7972, Taxpayer Workforce Modernization Act H.R. 8096, Duplication Scoring Act of 2026 H.R. 8134, Strengthen Taxpayer Rights Act of 2026 S. Res. 165, A resolution expressing the sense of the Senate that the plan of President Trump and Elon Musk to fire 83,000 employees of the Department of Veterans Affairs is unacceptable and must be rescinded. S. Res. 166, A resolution demanding the immediate reinstatement of all veteran Federal employees involuntarily removed or otherwise dismissed without cause since January 20, 2025. S. Res. 324, A resolution expressing the sense of the Senate that the actions of the Trump Administration that drastically and indiscriminately reduce staff at Federal agencies, freeze vast swaths of critical Federal funding, and dismantle Federal agencies are destructive and harmful to communities across the United States and have raised costs for American families. S. Res. 579, A resolution affirming the importance of the Social Security program to the people of the United States and expressing the sense of the Senate that Social Security must be preserved, protected, and strengthened for current and future generations. S. 21, REMOTE Act S. 26, To exclude locality adjustments from average pay for computing retirement annuities of new employees. S. 67, Censorship Accountability Act S. 82, Telework Reform Act of 2025 S. 102, ROOMIE Act S. 135, Wildland Firefighter Paycheck Protection Act of 2025 S. 295, Reducing the Federal Workforce Through Attrition Act S. 452, BARCODE Efficiency Act S. 490,Protecting Americans' Privacy Act S. 591, Restore Merit to Government Service Act of 2025 S. 727, U.S. Customs and Border Protection Officer Retirement Technical Corrections Act S. 949, Save Our Parks Act of 2025 S. 1059, One Agency Act S. 1138, A bill to require the Secretary of Homeland Security to enhance capabilities for outbound inspections at the southern land border, and for other purposes. S. 1154, Congressional Whistleblower Protection Act of 2025 S. 1185, FIGHTING for America Act of 2025 S. 1427, Audit the IRS Act S. 1444, Tax DODGER Act S. 1625, SHIELD Against CCP Act S. 1768, TALENTS Act S. 1771, Larry Henderson Act S. 1819, DOGE BROS Act S. 1871, Emerging Innovative Border Technologies Act S. 1923, CFPB Pay Fairness Act of 2025 S. 1991, Delivering On Government Efficiency in Spending Act S. 2039, Wildfire Risk Evaluation Act S. 2091, Restoring Lethality Act S. 2163, Border Patrol Recruitment Enhancement Act S. 2173, For Sale Act of 2025 S. 2429, Stop the Scammers Act S. 2473, Federal Firefighters Families First Act S. 2542, Federal Building Threat Notification Act S. 2595, Saving the Department of Energy's Workforce Act S. 2605, A bill to amend title 10, United States Code, to improve recruitment and retention of the cyber workforce of the Department of Defense, and for other purposes. S. 2645, DHS Suicide Prevention and Resiliency for Law Enforcement Act S. 2732, Bonuses for Cost-Cutters Act of 2025 S. 2786, Pipeline to Service Act S. 2816, Stop Sycophants in Government Act of 2025 S. 2838, Protecting Our Democracy Act S. 2953, Dismantling Double Dippers Act of 2025 S. 3091, DISPOSAL Act S. 3141, SAFE Act S. 3156, Federal Worker Mortgage Forbearance Act S. 3263, Stop TSP ESG Act S. 3283, Exclusive Citizenship Act of 2025 S. 3296, Improving Access to Workers Compensation for Injured Federal Workers Act of 2025 S. 3553, Wheres WALDO Act S. 3609, Community Protection and Wildfire Resilience Act S. 3619, Department of Defense Comprehensive Cyber Workforce Strategy Act of 2026 S. 3699, FOCUS Act S. 3755, Digital Commodity Intermediaries Act S. 3996, DHS Hiring Review Act S. 3997, Homeland Security Improvement Act S. 4099, Whistleblower Anti-Gag Act of 2026 S. 4100, A bill to amend title 5, United States Code, to clarify whistleblower protections for duty speech disclosures, and for other purposes. S. 4117, Federal Law Enforcement Officer Service Weapon Purchase Act of 2026 S. 4271, A bill to amend title 5, United States Code, to provide rest and recuperation leave for employees engaged in wildland firefighting, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33834,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"VORNDRAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":3778,"prefix":null,"prefix_display":null,"first_name":"REGINA","nickname":null,"middle_name":null,"last_name":"HUTTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45731,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOCKNAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138404,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOWARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65769,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TYREE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71319,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":"C","last_name":"SYBENGA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148450,"prefix":null,"prefix_display":null,"first_name":"MARAM","nickname":null,"middle_name":null,"last_name":"ABDELHAMID","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":45,"name":"Commodity Futures Trading Commission (CFTC)"},{"id":255,"name":"Consumer Financial Protection Bureau (CFPB)"},{"id":33,"name":"Energy, Dept of"},{"id":63,"name":"Federal Retirement Thrift Investment Board"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":65,"name":"General Services Administration (GSA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":67,"name":"Merit Systems Protection Board"},{"id":71,"name":"Natl Credit Union Administration (NCUA)"},{"id":143,"name":"Natl Park Service (NPS)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":81,"name":"Office of Personnel Management (OPM)"},{"id":82,"name":"Office of Special Counsel"},{"id":183,"name":"Office of the Comptroller of the Currency (OCC)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":88,"name":"Securities & Exchange Commission (SEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":184,"name":"U.S. Customs & Border Protection"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 1287, Fix FEDVIP Age Act H.R. 1597, Compassion for Vulnerable and Struggling Workers Act H.R. 1670, Family Building FEHB Fairness Act S. 797, The Family Building FEHB Fairness Act H.R. 2193, FEHB Protection Act of 2025 H.R. 4409, Fair Pharmacies for Federal Employees Act of 2025 H.R. 4648, Access to Fertility Treatment and Care Act S. 2408, Access to Fertility Treatment and Care Act H.R. 5127, PrEP and PEP are Prevention Act H.R. 6610, Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33834,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"VORNDRAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":3778,"prefix":null,"prefix_display":null,"first_name":"REGINA","nickname":null,"middle_name":null,"last_name":"HUTTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45731,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOCKNAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65769,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TYREE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138404,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOWARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71319,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":"C","last_name":"SYBENGA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148450,"prefix":null,"prefix_display":null,"first_name":"MARAM","nickname":null,"middle_name":null,"last_name":"ABDELHAMID","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":81,"name":"Office of Personnel Management (OPM)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"H. Res. 432, Providing for consideration of the bill (H.R. 2550) to nullify the Executive Order relating to Exclusions from Federal Labor-Management Relations Programs, and for other purposes. H.R. 20, Richard L. Trumka Protecting the Right to Organize Act of 2025 S. 852, Richard L. Trumka Protecting the Right to Organize Act of 2025 H.R. 1210, Protecting Taxpayers' Wallets Act of 2025 S. 511, Protecting Taxpayers' Wallets Act of 2025 H.R. 2086, Rights for the TSA Workforce Act S. 997, Rights for the TSA Workforce Act H.R. 2174, The Paycheck Protection Act S. 1597, Paycheck Protection Act H.R. 2249, Preserving Presidential Management Authority Act H.R 2297, Taxpayer-Funded Union Time Transparency Act S. 1170, Taxpayer-Funded Union Time Transparency Act H.R. 2550, Protect America's Workforce Act S. 2837, Protect Americas Workforce Act H.R. 2671, Tax Fairness for Workers Act S. 1286, Tax Fairness for Workers Act H.R. 2676, No Union Time on the Taxpayers Dime Act S. 1313, No Union Time on the Taxpayer's Dime Act H.R. 5749, Official Time Reporting Act H.R. 6136, PURE Act H.R. 6139, Union Members Right to Know Act S. 3114, Union Members Right to Know Act H.R. 6156, Endorsement Transparency Act S. 1006, Federal Workforce Freedom Act S. 3766, Make Congress Drive Union Made Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33834,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"VORNDRAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":3778,"prefix":null,"prefix_display":null,"first_name":"REGINA","nickname":null,"middle_name":null,"last_name":"HUTTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45731,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOCKNAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138404,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"SOWARDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65769,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TYREE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71319,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":"C","last_name":"SYBENGA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148450,"prefix":null,"prefix_display":null,"first_name":"MARAM","nickname":null,"middle_name":null,"last_name":"ABDELHAMID","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":255,"name":"Consumer Financial Protection Bureau (CFPB)"},{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":143,"name":"Natl Park Service (NPS)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":81,"name":"Office of Personnel Management (OPM)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ae8c5c84-c5f0-40fa-ad6f-02b549499069/","filing_uuid":"ae8c5c84-c5f0-40fa-ad6f-02b549499069","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/ae8c5c84-c5f0-40fa-ad6f-02b549499069/print/","filing_document_content_type":"text/html","income":null,"expenses":"190000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael DeRose","dt_posted":"2026-04-16T12:48:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"Grand Central Station, PO Box 4777","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10163","registrant":{"id":401104060,"url":"https://lda.gov/api/v1/registrants/401104060/","house_registrant_id":null,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","description":"Parkinson's disease research","address_1":"Grand Central Station, PO Box 4777","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10163","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL DEROSE","contact_telephone":"+1 212-509-0995","dt_updated":"2026-07-23T15:55:48.243467-04:00"},"client":{"id":200707,"url":"https://lda.gov/api/v1/clients/200707/","client_id":12,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Federal funding for Parkinsons disease and neurodegenerative disease research, care, and public health programs in Fiscal Year (FY) 2026 and FY 2027 appropriations legislation, including advocacy related to funding levels, report language, and congressional appropriations requests. Support overall funding increases for medical research and neurological condition research across NIH, ARPA-A, DOD, and VA. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy for appropriations to support implementation of the National Parkinsons Project (NPP), advisory council activities, and related reporting requirements consistent with enacted appropriations language. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations for Parkinsons disease and related conditions across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)), and increasing investment for neurological disease research such as the BRAIN Initiative. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy for appropriations and related report language to expand the Udall Centers. Advanced Research Projects Agency for Health (ARPA-H), including advocacy for report language directing prioritization of neurodegenerative disease research and alignment with emerging opportunities in chronic disease and aging research. Department of Health and Human Services (HHS) environmental risk and prevention efforts, including advocacy for report language and appropriations to support interagency coordination and research on toxic exposures and neurodegenerative disease prevention. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research funding, including advocacy for report language to expand eligibility to Parkinsons disease and related dementias. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support surveillance and data collection on Parkinsons disease and related conditions. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program (TERP) to support research on Parkinsons disease and service-related exposures. Department of Veterans Affairs (VA) Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Neurology Centers of Excellence, including advocacy for increased appropriations and report language to support research, clinical care, and access for veterans living with Parkinsons disease. Department of Veterans Affairs (VA) Office of Research and Development (ORD), including advocacy for report language to increase focus on Parkinsons disease and related conditions within VAs medical research portfolio. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), including advocacy for appropriations and report language supporting research on toxic exposures and Parkinsons disease. Food and Drug Administration (FDA) neurodegenerative disease guidance and reporting, including advocacy for report language to improve coordination, transparency, and disease-specific guidance for Parkinsons disease and related conditions. Food and Drug Administration (FDA) Neurology Drug Program to coordinate efforts on central nervous system drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug affordability and access for individuals with Parkinsons disease and other chronic conditions, including advocacy related to patient access to medications, cost-sharing, and barriers to accessing clinically appropriate medications. Prescription drug coverage and access under Medicare, including advocacy related to policies impacting access to Parkinsons disease treatments, formulary placement, and utilization management.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical research, clinical care, and access to services for veterans living with Parkinsons disease and other neurological conditions, including advocacy related to programs, research, and exposure-related risk factors within the Department of Veterans Affairs (VA) and Department of Defense (DOD). Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Department of Veterans Affairs (VA) Neurology Centers of Excellence, including advocacy for appropriations and report language to support specialized care, research, and access to services for veterans living with Parkinsons disease. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program to support research on Parkinsons disease and service-related exposures. Research on service-related exposures and Parkinsons disease, including advocacy related to toxic exposures, traumatic brain injury, and other risk factors associated with military service and increased risk of neurodegenerative disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Environmental exposures and toxic substances linked to Parkinsons disease, including advocacy related to reducing or eliminating exposure to chemicals such as paraquat and other environmental contaminants associated with increased risk of neurodegenerative disease. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for research on environmental risk factors and toxic exposures linked to neurodegenerative diseases.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax policy related to financial support for family caregivers and individuals with chronic conditions, including advocacy to reduce out-of-pocket costs and improve affordability of care. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Credit for Caring Act of 2025 (S. 925 / H.R. 2036), including advocacy related to providing a nonrefundable tax credit to offset caregiving expenses for working family caregivers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, beneficiary protections, and the CY 2027 Advance Notice.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ae8c5c84-c5f0-40fa-ad6f-02b549499069/","filing_uuid":"ae8c5c84-c5f0-40fa-ad6f-02b549499069","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/ae8c5c84-c5f0-40fa-ad6f-02b549499069/print/","filing_document_content_type":"text/html","income":null,"expenses":"190000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael DeRose","dt_posted":"2026-04-16T12:48:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"Grand Central Station, PO Box 4777","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10163","registrant":{"id":401104060,"url":"https://lda.gov/api/v1/registrants/401104060/","house_registrant_id":null,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","description":"Parkinson's disease research","address_1":"Grand Central Station, PO Box 4777","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10163","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL DEROSE","contact_telephone":"+1 212-509-0995","dt_updated":"2026-07-23T15:55:48.243467-04:00"},"client":{"id":200707,"url":"https://lda.gov/api/v1/clients/200707/","client_id":12,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Federal funding for Parkinsons disease and neurodegenerative disease research, care, and public health programs in Fiscal Year (FY) 2026 and FY 2027 appropriations legislation, including advocacy related to funding levels, report language, and congressional appropriations requests. Support overall funding increases for medical research and neurological condition research across NIH, ARPA-A, DOD, and VA. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy for appropriations to support implementation of the National Parkinsons Project (NPP), advisory council activities, and related reporting requirements consistent with enacted appropriations language. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations for Parkinsons disease and related conditions across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)), and increasing investment for neurological disease research such as the BRAIN Initiative. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy for appropriations and related report language to expand the Udall Centers. Advanced Research Projects Agency for Health (ARPA-H), including advocacy for report language directing prioritization of neurodegenerative disease research and alignment with emerging opportunities in chronic disease and aging research. Department of Health and Human Services (HHS) environmental risk and prevention efforts, including advocacy for report language and appropriations to support interagency coordination and research on toxic exposures and neurodegenerative disease prevention. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research funding, including advocacy for report language to expand eligibility to Parkinsons disease and related dementias. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support surveillance and data collection on Parkinsons disease and related conditions. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program (TERP) to support research on Parkinsons disease and service-related exposures. Department of Veterans Affairs (VA) Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Neurology Centers of Excellence, including advocacy for increased appropriations and report language to support research, clinical care, and access for veterans living with Parkinsons disease. Department of Veterans Affairs (VA) Office of Research and Development (ORD), including advocacy for report language to increase focus on Parkinsons disease and related conditions within VAs medical research portfolio. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), including advocacy for appropriations and report language supporting research on toxic exposures and Parkinsons disease. Food and Drug Administration (FDA) neurodegenerative disease guidance and reporting, including advocacy for report language to improve coordination, transparency, and disease-specific guidance for Parkinsons disease and related conditions. Food and Drug Administration (FDA) Neurology Drug Program to coordinate efforts on central nervous system drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug affordability and access for individuals with Parkinsons disease and other chronic conditions, including advocacy related to patient access to medications, cost-sharing, and barriers to accessing clinically appropriate medications. Prescription drug coverage and access under Medicare, including advocacy related to policies impacting access to Parkinsons disease treatments, formulary placement, and utilization management.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical research, clinical care, and access to services for veterans living with Parkinsons disease and other neurological conditions, including advocacy related to programs, research, and exposure-related risk factors within the Department of Veterans Affairs (VA) and Department of Defense (DOD). Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Department of Veterans Affairs (VA) Neurology Centers of Excellence, including advocacy for appropriations and report language to support specialized care, research, and access to services for veterans living with Parkinsons disease. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program to support research on Parkinsons disease and service-related exposures. Research on service-related exposures and Parkinsons disease, including advocacy related to toxic exposures, traumatic brain injury, and other risk factors associated with military service and increased risk of neurodegenerative disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Environmental exposures and toxic substances linked to Parkinsons disease, including advocacy related to reducing or eliminating exposure to chemicals such as paraquat and other environmental contaminants associated with increased risk of neurodegenerative disease. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for research on environmental risk factors and toxic exposures linked to neurodegenerative diseases.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax policy related to financial support for family caregivers and individuals with chronic conditions, including advocacy to reduce out-of-pocket costs and improve affordability of care. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Credit for Caring Act of 2025 (S. 925 / H.R. 2036), including advocacy related to providing a nonrefundable tax credit to offset caregiving expenses for working family caregivers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, beneficiary protections, and the CY 2027 Advance Notice.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3a7a812d-63a4-4f94-be5b-966857ce4bd4/","filing_uuid":"3a7a812d-63a4-4f94-be5b-966857ce4bd4","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3a7a812d-63a4-4f94-be5b-966857ce4bd4/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"M'liss Reingruber","dt_posted":"2026-04-20T09:46:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5614 Connecticut Ave NW #288","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20015","registrant":{"id":401105571,"url":"https://lda.gov/api/v1/registrants/401105571/","house_registrant_id":null,"name":"USAGAINSTALZHEIMERS ACTION","description":"Advocacy organization","address_1":"5614 Connecticut Ave NW #288","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20015","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"M'LISS REINGRUBER","contact_telephone":"+1 202-349-3803","dt_updated":"2026-07-22T10:55:30.938145-04:00"},"client":{"id":206248,"url":"https://lda.gov/api/v1/clients/206248/","client_id":12,"name":"USAGAINSTALZHEIMERS ACTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-07-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 7147, H.R. 7148 - Consolidated Appropriations Act; Issues related to the Presidents FY2027 Budget Proposal; Issues related to funding for NIH; Issues related to funding for CDC; Issues related to funding for CMS; Issues related to funding for Alzheimer's research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; Issues related to the extension of the enhanced advanced premium tax credits; Issues related to the Affordable Care Act and comprehensive healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 247, S. 46 - Health Care Affordability Act of 2025; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; Issues related to improving strategies for early detection and prevention of Alzheimers; Issues related to the Affordable Care Act and comprehensive healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/97697ad8-cd57-4da4-a7e0-94a8555ee7b9/","filing_uuid":"97697ad8-cd57-4da4-a7e0-94a8555ee7b9","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/97697ad8-cd57-4da4-a7e0-94a8555ee7b9/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tricia Brooks","dt_posted":"2026-04-20T13:44:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"200 Metro Boulevard","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Nutley","registrant_state":"NJ","registrant_zip":"07110","registrant":{"id":400321512,"url":"https://lda.gov/api/v1/registrants/400321512/","house_registrant_id":40258,"name":"EISAI INC.","description":"Pharmaceutical development, manufacturing and distribution -- Health Care","address_1":"200 Metro Boulevard","address_2":null,"address_3":null,"address_4":null,"city":"Nutley","state":"NJ","state_display":"New Jersey","zip":"07110","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TRICIA BROOKS","contact_telephone":"+1 202-934-3735","dt_updated":"2026-07-22T11:30:31.993646-04:00"},"client":{"id":189281,"url":"https://lda.gov/api/v1/clients/189281/","client_id":12,"name":"EISAI INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-28"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; Alzheimers Screening and Prevention Act (ASAP) (HR 6130, S 3267); Concentrating on High-value Alzheimers Needs to Get to an End Act (CHANGE) (HR 4752. S 2379).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to supply chain manufacturing and tariffs; Section 232 tariff investigation on branded pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to pharmaceutical Intellectual Property (IP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to pharmaceutical manufacturing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e8e7b414-e066-4ab6-a68c-95ef70ab621c/","filing_uuid":"e8e7b414-e066-4ab6-a68c-95ef70ab621c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e8e7b414-e066-4ab6-a68c-95ef70ab621c/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-04-20T13:55:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c8ba90c5-7f4d-4abe-a7a7-0795e0b6e14c/","filing_uuid":"c8ba90c5-7f4d-4abe-a7a7-0795e0b6e14c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/c8ba90c5-7f4d-4abe-a7a7-0795e0b6e14c/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"David Bergman","dt_posted":"2026-04-20T15:13:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7700 Old Georgetown Road, Suite 250","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Bethesda","registrant_state":"MD","registrant_zip":"20814","registrant":{"id":1546,"url":"https://lda.gov/api/v1/registrants/1546/","house_registrant_id":30523,"name":"AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE","description":null,"address_1":"7700 Old Georgetown Road","address_2":"Suite 250","address_3":null,"address_4":null,"city":"Bethesda","state":"MD","state_display":"Maryland","zip":"20814","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID BERGMAN","contact_telephone":"+1 703-801-5518","dt_updated":"2026-07-09T16:12:43.740732-04:00"},"client":{"id":102625,"url":"https://lda.gov/api/v1/clients/102625/","client_id":12,"name":"AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Dr. Lorna Breen Health Care Provider Protection Act (H.R 929, S. 266) Rural Physician Workforce Production Act (H.R. 1153) Physicians for Underserved Areas Act (H.R. 870, S. 1044) Rural Health Innovation Act of 2025 (H.R.1480) Fair Access In Residency Act (H.R. 2314/S.2715) Teaching Health Center Graduate Medical Education National Institutes of Health Research Pathways to Health Professions Act (H.R. 593) Bipartisan Rural America Health Corps Act (H.R. 1127) Expanding Medical Education Act (H.R. 2106, S. 975) Community TEAMS Act (H.R. 3885, S.3989) Specialty Physicians Advancing Rural Care Act (S. 1380) Post GRAD Act (H.R. 3711) Physician and Patient Safety Act (H.R. 3413, S. 1767) IHS Workforce Production Act ( S.632) Rural Health Focus Act (S.403) Rural Health Transformation Program Healthcare Advisory Council Resident Physician Shortage Reduction Act (H.R.4731/S.2439) Medical Student Education Authorization Act (H.R.5248) Palliative Care and Hospice Education and Training Act (S.2287) Improving Care in Rural America Reauthorization Act (S.2301) Health Care Workforce Expansion Act (S.2954) Resident Education Deferred Interest (REDI Act) (H.R. 2028,S. 942) Save Americas Rural Hospitals Act (H.R. 3684) Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act (H.R. 4262) Train More Primary Care Doctors Act of 2025 (H.R. 958) Rural Hospital Flexibility Act (S. 3250) Rural Behavioral Health Improvement Act (H.R.5217) Community Health Workforce Development Act (H.R. 7289) Student Loan Tax Elimination Act (H.R. 3165 / S.3538) Healthcare is Human Act of 2026 (H.R. 7884) Rural Residency Planning and Development Act of 2025 (H.R. 6468) Healthcare Education in AI Literacy (HEAL A.I.) Act (H.R. 6077) PSLF Payment Completion Fairness Act (H.R. 3267 / S.3487) Foreign Medical School Accountability Fairness Act (S. 3757) Medically Tailored Home-Delivered Meals Program Pilot Act (H.R. 5439, S. 2834) Nutrition Education Community Academic Health Systems","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"One Big Beautiful Bill Act (H.R. 1) Student Financial Aid Financial value transparency and gainful employment Artificial Intelligence Institutional risk sharing and accountability Public Service Loan Forgiveness Program Accreditation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY26 Budget and Appropriations Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill Osteopathic Research And Representation Continuing Appropriations and Extensions Act, 2026 (H.R.5371) FY27 Budget and Appropriations Community Academic Health Systems Osteopathic Manipulative Treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"VA Medical Research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2e772a20-fb1d-481d-bfdd-3772e1b61812/","filing_uuid":"2e772a20-fb1d-481d-bfdd-3772e1b61812","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2e772a20-fb1d-481d-bfdd-3772e1b61812/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Adina Lasser","dt_posted":"2026-04-20T15:31:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/673d4471-decf-4b13-aecd-f56014c37377/","filing_uuid":"673d4471-decf-4b13-aecd-f56014c37377","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/673d4471-decf-4b13-aecd-f56014c37377/print/","filing_document_content_type":"text/html","income":null,"expenses":"490000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-04-20T15:47:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2023 (H.R. 2408 118th Congress) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718 118th Congress) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act (S. 2287/H.R. 4425 119th Congress) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2584 118th Congress) Alleviating Barriers for Caregiving Act (S. 3109 118th Congress) Credit for Caring Act of 2025 (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 (S. 2016/H.R. 4189 118th Congress; S. 1261/H.R. 4206 119th Congress) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Timely Access to Care Act of 2025 (S. 1816/H.R. 3514 119th Congress) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act of 2026 (H.R. 7779 119th Congress) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766 119th Congress) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343 119th Congress) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 8588, 118th Congress) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029) Catching Up Family Caregivers Act (S. 5149 / H.R. 9764, 118th Congress) Improving Retirement Security for Family Caregivers Act (S. 5148 / H.R. 9765, 118th Congress) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565 / H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/62be78da-baaa-4544-aef9-54d70fb49e89/","filing_uuid":"62be78da-baaa-4544-aef9-54d70fb49e89","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/62be78da-baaa-4544-aef9-54d70fb49e89/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Carol Ann Schwartz, Hadassah National President","dt_posted":"2026-04-21T11:38:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"40 WALL STREET","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW YORK","registrant_state":"NY","registrant_zip":"10005","registrant":{"id":52925,"url":"https://lda.gov/api/v1/registrants/52925/","house_registrant_id":34920,"name":"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.","description":"NON-PROFIT ORGANIZATION","address_1":"40 WALL STREET","address_2":null,"address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROL ANN SCHWARTZ","contact_telephone":"+1 513-271-7600","dt_updated":"2026-07-17T10:37:20.309443-04:00"},"client":{"id":157951,"url":"https://lda.gov/api/v1/clients/157951/","client_id":12,"name":"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-01"},"lobbying_activities":[{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"H.R. 5645/S. 2947 - Pray Safe Act of 2025 All provisions. This bill establishes the Federal Clearinghouse on Safety and Best Practices for Nonprofit Organizations, Faith-based Organizations, and Houses of Worship within the Department of Homeland Security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"H.R. 8119 - HOPE with Fertility Services Act All provisions. This bill requires group health plans that cover obstetrical services to also cover infertility diagnosis, treatment, and standard fertility preservation services.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"H.R. 2588/S. 3724 - Improving Reporting to Prevent Hate Act of 2025 All provisions. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to include certain reporting to the uniform crime reporting program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"HR 661 - MIRACLE Medical Technology Act of 2025 All provisions This bill requires the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services. H.R. 764/S. 280 - Global Health, Empowerment and Rights Act All provisions This bill prohibits determining ineligibility of foreign nongovernmental organizations to receive assistance solely on the basis of health or medical services, including counseling and referral services, provided by such organizations with non-United States Government funds if such services do not violate the laws of the country in which they are being provided. H.R. 1229/S. 554 - United States-Israel Defense Partnership Act of 2025 All provisions This bill enhances bilateral defense cooperation between the United States and Israel. H.R. 2439/ S.3393 - Support UNFPA Funding Act All provisions This bill authorizes contributions to the United Nations Population Fund. H.R. 2609 - PEACE Act All provisions This bill promotes education and training to United States diplomatic personnel relating to the Abraham Accords and other normalization agreements with Israel. H.R. 3565 - To provide for a limitation on the transfer of defense articles and defense services to Israel. All provisions This bill provides for a limitation on the transfer of defense articles and defense services to Israel. H.R. 4473 - BIRD Health Act of 2025 All provisions This bill directs the Secretary of Health and Human Services to establish a bilateral research and innovation program to facilitate and coordinate efforts between the United States and Israel in certain health-related areas. H.R. 4655 - United States-Israel PTSD Collaborative Research Act All provisions This bill directs the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel. H.Res. 525 - Affirming the role of the United States in eliminating sexual violence in conflict. All provisions This resolution affirms the role of the United States in eliminating sexual violence in conflict. S.Res. 410 - A resolution calling on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. All provisions This resolution calls on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. S.J.Res. 136, S.J.Res. 137, S.J.Res. 138 - A joint resolution providing for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. All provisions. These resolutions provide for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. H.R. 7018/S. 1521 - Stand with Israel Act of 2026 All provisions. This bill limits funding for United States participation in the United Nations if Israel is illegally expelled. H.R. 7540/S. 3855 - United States-Israel FUTURES Act of 2026 All provisions. This bill enhances bilateral defense cooperation between the United States and Israel.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/ S. 1410- Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care under the laws administered by the Secretary without requiring a referral.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 768/S. 332 - Holocaust Education and Antisemitism Lessons Act All provisions This bill directs the U.S. Holocaust Memorial Museum to study and report on Holocaust education efforts in states, local educational agencies (LEAs), and public elementary and secondary schools. H.R. 5714 - October 7 Remembrance Education Act All provisions. This bill directs the United States Holocaust Memorial Museum to develop a curriculum for the study of antisemitism surrounding Hamas October 7, 2023, terrorist attacks against Israel.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"H.R. 1007/S. 558 Antisemitism Awareness Act of 2025 All provisions This bill provides for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and for other purposes. H.R. 15/S. 1503 - Equality Act All provisions This bill prohibits discrimination on the basis of sex, gender identity, and sexual orientation. H.R. 3691 - Commission to Study Acts of Antisemitism in the United States Act All provisions This bill establishes the Commission to Study Acts of Antisemitism in the United States to investigate the causes of antisemitism and provide policy recommendations to Congress and the President. H.R. 6857/S. 163 - Protecting Students on Campus Act of 2025 All provisions This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FAM","general_issue_code_display":"Family issues/Abortion/Adoption","description":"H.R. 999/S. 422 - Right to Contraception Act All provisions This bill would safeguard Americans right to access all forms of birth control and protect against federal and state efforts to restrict it. H.R. 1197/S. 1562 - PREEMIE Reauthorization Act of 2025 All provisions This bill reauthorizes the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act through FY2029 and establishes actions by the Department of Health and Human Services (HHS) to address preterm birth (i.e., babies born before 37 weeks of pregnancy). H.R. 1670/S. 797 - Family Building FEHB Fairness Act All provisions This bill adds a requirement for Federal employee health benefit plans to include assisted reproductive treatment benefits. H.R. 1878 - IVF Access and Affordability Act All provisions This bill introduces a tax credit for fertility treatments, capping at $20,000 annually, with provisions for joint filers, income-based reductions, and a five-year carryforward for unused credits, effective for taxable years post-enactment. H.R. 2049 - Access to Family Building Act All provisions This bill provides a statutory right to access assisted reproductive technology (e.g., in vitro fertilization). H.R. 2557/S. 1231 - IVF for Military Families Act All provisions This bill amends title 10, United States Code, to provide fertility treatment under the TRICARE Program. H.R. 2762/S. 1394 Expanding Access to Family Planning Act All provisions This bill provides enhanced funding for family planning services. S. 2035 Protect IVF Act All provisions This bill establishes statutory rights to choose to receive, provide, and cover fertility treatments. H.R. 12 - Womens Health Protection Act of 2025 All provisions This bill protects a persons ability to determine whether to continue or end a pregnancy, and to protect a health care providers ability to provide abortion services. H.R. 4611/S. 2377 - EACH Act of 2025 All provisions This bill aims to ensure affordable abortion coverage and care for every person. H.R. 4648/S. 2408 - Access to Fertility Treatment and Care Act All provisions This bill will require health insurance plans to provide coverage for fertility treatment. H.R. 4888/S. 2671 - Reproductive Rights are Human Rights Act of 2025 All provisions This bill will amend the Foreign Assistance Act of 1961 to require a section on reproductive rights in the Annual Country Reports on Human Rights Practices. H.R. 4977/S. 141 - Connected MOM Act All provisions This bill identifies and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women. H.R. 6945 - Supporting Pregnant and Parenting Women and Families Act All provisions This bill amends part A of title IV of the Social Security Act to clarify the authority of States to use funds for pregnancy centers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 Provisions related to increasing the authorized funding for the Nonprofit Security Grant Program This bill makes appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2026. H.R. 7148 Consolidated Appropriations Act, 2026; H.R. 7006 Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026; H.R. 7147 Further Additional Continuing Appropriations Act, 2026; H.R. 7744 Department of Homeland Security Appropriations Act, 2026 Provisions for increased funding and staff for the Office of the Special Envoy to Monitor and Combat Antisemitism for FY 2026; funding for the Special Envoy for Holocaust Issues; increasing the authorized funding for the Nonprofit Security Grant Program; security and defense partnerships with Israel including US-Israel missile defense cooperation on Iron Dome and Davids Sling and Arrow defense systems; US-Israel Anti-Tunneling Cooperation; access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. These bills make appropriations for the fiscal year ending September 30, 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"H.R. 5011 - Violent Antisemitism Threat Assessment Act All provisions This bill will require a report from the Secretary of Defense to the House and Senate Committees on Armed Services on the threat posed by violent antisemitism as a component of transnational extremist movements. H.R. 5681 - STOP HATE Act of 2025 All provisions. This bill requires the reporting of certain terms of service of social media companies for purposes of limiting the online presence of terrorist organizations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/71c734f4-f444-41b8-a10d-ae8f440a1f97/","filing_uuid":"71c734f4-f444-41b8-a10d-ae8f440a1f97","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/71c734f4-f444-41b8-a10d-ae8f440a1f97/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"David Taboh","dt_posted":"2026-04-23T13:37:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"328 Massachusetts Avenue, NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":27866,"url":"https://lda.gov/api/v1/registrants/27866/","house_registrant_id":30744,"name":"NATIONAL FRATERNAL ORDER OF POLICE","description":null,"address_1":"328 Massachusetts Avenue NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES O. PASCO, JR.","contact_telephone":"","dt_updated":"2026-07-30T10:49:36.743974-04:00"},"client":{"id":134463,"url":"https://lda.gov/api/v1/clients/134463/","client_id":12,"name":"NATIONAL FRATERNAL ORDER OF POLICE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"PASSED HOUSE - H.R. 27 (Griffith, R-VA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Controlled Substances Act. H.R. 378 (Buchanan, R-FL) the Thin Blue Line Act, which would expand the list of aggravating factors in death penalty determinations for those who target, kill, or attempt to kill a law enforcement or other public safety officer; H.R. 503 (Foxx, R-NC) the Qualified Immunity Act, which would codify the existing qualified immunity doctrine; H.R. 621 (Joyce, R-OH), the Protecting First Responders from Secondary Exposure Act, which would allow State and local governments to purchase containment devices through the existing Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP); H.R. 633 (Salazar, R-FL) the Tools to Address Known Exploitation by Immobilizing Technological Deepfakes on Websites and Network (TAKE IT DOWN) Act, which would clarify and expand agency authority to combat the distribution of exploitative deepfake technology; H.R. 911 (Fitzpatrick, R-FL) the Patriot Day Act, which would establish September 11th as a permanent Federal holiday; H.R. 993 (Correa, D-CA) the Directing Resources for Officers Navigating Emergencies (DRONE) Act, which would allow law enforcement agencies to use Edward R. Byrne Memorial Justice Assistance Grant (Byrne-JAG) funds to help purchase and operate unmanned aircraft systems; H.R. 1046 (Bacon, R-NE) the Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act, which would require the Director of the Bureau of Prisons to develop and implement a strategy to interdict fentanyl and other synthetic drugs in the mail at Federal correctional facilities; H.R. 1236 (Barr, R-KY) the Chief Herbert D. Proffitt Act, which would amend the Public Safety Officers Benefits program and allow survivors to file for death or disability benefits for officers no in active service, provided their death or disability was connected to their service as a law enforcement officer; H.R. 1260 (Malliotakis, R-NY) the U.S. Park Police Modernization Act, which would address the growing crisis that faces the USPP and its ability to protect and serve the public; H.R. 1266 (Panetta, D-CA), the Combating Illicit Xylazine Act, which would appropriate steps to add xylazine to the Controlled Substances Act; H.R. 1269 (Scanlon, D-PA) the Honoring Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program; H.R. 1443 (Van Drew, R-NJ) the Public Safety Free Speech Act, which would clarify and protect the speech of a public safety employee by allowing them to take legal action against an employer who violates this right; TOP PRIORITY - H.R. 1505 (Stauber, D-MN) the Public Safety Employer-Employee Cooperation Act, which would guarantee public safety officers the right to form and join unions and bargain collectively with their employers over wages, hours, and working conditions; PRIORITY - H.R. 1551 (Rutherford, R-FL) the Protect and Serve Act, which would impose Federal penalties on individuals who deliberately target local, State or Federal law enforcement officers with violence; H.R. 1556 (Bresnahan, R-PA) Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of a Federal capital case if the first jury does not reach a unanimous decision on the sentence; H.R. 1726 (Neguse, D-CO) the Project Safe Neighborhoods Reauthorization Act, which would reauthorize critical funding and support for local law enforcement agencies and community organizations that help reduce violent crime and enhance public safety; H.R. 1773 (Rutherford, R-FL) the Federal Firearms Licensee Protection Act, which would make firearm thefts a Federal offense punishable by up to 20 years in prison; H.R. 2305 (Miller-Meeks, R-IA) the Corrections Officer Blake Schwarz Suicide Prevention Act, which would establish a grant program that would provide funding to the Federal Bureau of Prisons, States, and localities to carry out mental health screenings and provide referrals, where applicable, to mental healthcare providers for those corrections officers who are struggling with their mental health; PRIORITY - H.R. 2094 (Rutherford, R-FL) the Homes for Every Local Protector, Educator, and Responder (HELPER) Act, which would give law enforcement more opportunities to find homes they can afford on a public servants salary based on the VA home loan program; H.R. 2096 (Garbarino, R-NY) the Protecting Our Nations Capital Emergency Act. which would restore the collective bargaining rights, non-disclosure protections, and disciplinary protocols of MPD officers that were lost in the implementation of the CPJRAA; H.R. 2194 (Harder, D-CA) the HIDTA Enhancement Act, which would increase the HIDTA programs budget by over $28 million to provide for the creation of new grant programs in order to enhance fentanyl seizure operations and improve coordination between law enforcement agencies; H.R. 2189 (Fitzgerald, R-WI) the Law Enforcement Innovate to De-Escalate Act, which would establish the term less-than-lethal projectile device in Federal statute to ensure that these devices are properly classified by the U.S. Department of Justice (DOJ) based on a new five step criteria; H.R. 2240 (Moore, R-NC) the Improving Law Enforcement Officer Safety and Wellness Through Data Act, which would expand the data collected by the Federal government on attacks and aggressions against law enforcement officers in a comprehensive way; H.R. 2502 (Kaptur, D-OH) the Law Enforcement Training for Mental Health Crisis Response Act, which would provide grants to law enforcement departments at the state, local, territorial, and tribal level to obtain vital behavioral health crisis response training to resolve behavioral health crisis situations more safely and effectively; H.R. 2654 (Stauber, D-MN), the Lifesaving Gear for Police Act, which would protect the important surplus equipment programs for State and local law enforcement, like the 1033 program, from politically-driven interference and competing Executive Orders; H.R. 2711 (Gottheimer, D-NJ,) the Invest to Protect Act, which would establish a grant program, administered by the Community Oriented Policing Services (COPS) Office within the U.S. Department of Justice (DOJ), that would be used for the training of officers from police departments and municipalities that employ fewer than 175 law enforcement officers; H.R. 2735 (Nehls, R-TX) the Strengthening Child Exploitation Enforcement Act, which would close loopholes in Federal child abuse criminal statutes. H.R. 2752 (Van Drew, R-NJ) the Ensuring Safer Schools Act, which would amend the Omnibus Crime Control and Safe Streets Act of 1968 by allowing funds from the DOJs Office of Community Oriented Policing Services (COPS) to be utilized for the training of military veterans and retired law enforcement officers to become school resource officers; H.R. 2964 (Taylor, R-OH) the Fight Fentanyl Act, which would provide over $333 million annually for the HIDTA program and allow for and support programs that would enhance fentanyl seizure operations and improve coordination between law enforcement agencies. H.R. 3267 (Houlahan, D-PA), the Public Service Loan Forgiveness (PSLF) Payment Completion Fairness Act, which would eliminate a technicality in the law that requires an applicant to be employed in a public service job to qualify for public loan forgiveness; H.R. 3366 (Pappas, D-NH), the Establishing Accreditation Grants for Law Enforcement (EAGLE) Act, which would establish a grant program that would pay the certification or re-certification fees for small and mid-sized law enforcement agencies; H.R. 3372 (Sykes, D-OH), the Law Enforcement Scenario-Based Training for Safety and De-Escalation Act, which would direct the Office of Community Oriented Policing Services (COPS) to authorize grants to State and local law enforcement agencies to provide law enforcement personnel access to an immersive, real-life, scenario-based training curriculum; H.R. 3398 (Kennedy, D-NY), the Aaron Salter, Jr. Responsible Body Armor Protection Act, which would bar civilians from purchasing, owning, or possessing enhanced body armor with ballistic resistance that meets or exceeds the RF1 standard; H.R. 3598 (Nehls, R-TX,) the De-escalation Drone Pilot Program Act, which would establish a pilot program for small, nonlethal deescalation unmanned aircraft to be used for law enforcement and public safety, and for other purposes. H.R.3832 (Bacon, R-NE), the Kerrie Orozco First Responders Family Support Act, which would allow a surviving spouse, child, or parent of a U.S. citizen public safety officer who died in service or as a result of their service to apply for U.S. citizenship more quickly by waiving the five-year continuous residence and the 30-month physical presence requirements for naturalization. H.R.4024 (Carbajal, D-CA), the Filling Public Safety Vacancies Act, which would provide a needed one-time boost of $162 million for the hiring program administered by the Office of Community Oriented Policing Services (COPS); H.R. 4334 (Kustoff, R-TN), the Restoring the Armed Career Criminal Act, which would better equip Federal prosecutors to pursue criminals; H.R. 4607 (Neguse, D-C0) the Samaritan Efforts to Ensure Key Health Emergency and Life-saving Protections (SEEK HELP) Act, which would close gaps in the Good Samaritan laws by ensuring that people cannot be prosecuted for drug possession when they seek medical assistance after witnessing or experiencing an overdose; H.R. 5282 (Reschenthaler, R-NY) the Reauthorizing Supporting and Treating Officers in Crisis (STOIC) Act, which would reauthorize funds made available from the DOJs Office of Community Oriented Policing Services (COPS) to continue services for law enforcement officers and their families to include stress reduction and suicide prevention through 2029; H.R. 5391 (Deluzio, D-PA) the Bipartisan Bulletproof Vest Partnership Program Expansion Act, which would increase reauthorization of the Patrick J. Leahy Bulletproof Vest Partnership program; H.R. 5403 (Landsman, D-OH) the Enhancing COPS Hiring Program Grants for Local Law Enforcement Act, which would allow funds administered by the DOJs Office of Community Oriented Policing Services (COPS) to be used to provide bonuses for the recruitment and retention of law enforcement officers; H.R 5594 (McDonald Rivet, D-MI) the Protect Your Pin Act, which would expand guidelines to allow local law enforcement agencies to use grant funding from the U.S. Department of Justices Local Law Enforcement Grants for Enforcement of Cybercrimes program to combat identity theft. H.R. 5744 (Vindman, D-VA) the Targeting Online Sales of Fentanyl Act, which would direct the GAO to investigate the methods used to enable online its sales and assess the procedures and efforts of Federal law enforcement and online providers in combating such; H.R. 6042 (Smith, R-NJ) the Law Against Nefarious Drones, Enforcement, Deconfliction (LANDED) Act, which would create policies for acquiring and deploying approved counter-UAS detection systems, authorize processes for State agencies to detect, monitor, and mitigate drone threats, and establish a grant program to fund equipment and training; H.R. 5107 (Clyde, R-GA) the Common-Sense Law Enforcement and Accountability Now in DC (CLEAN DC) Act, which would repeal the entirety of D.C.s Comprehensive Policing and Justice Reform Amendment Act of 2022. This legislation goes beyond just the restoration of the collective bargaining provisions and would also eliminate restrictive measures that have hampered the ability of the officers serving the Washington, D.C. Metropolitan Police Department (MPD) to do their jobs and allow them to perform their duties more effectively while maintaining essential protections; H.R. 6120 (Zinke, R-MT) the Strengthening Resources for Our Schools (SROs) Act, which would mend existing law to offer a Federal income tax exemption on retirement pay for any officer or veteran who chooses to serve as a School Resource Officer; H.R. 6602 (Torres, D-CA) the Supporting Blue Envelope Programs Act, which would allow individuals with Autism Spectrum Disorder (ASD) and Intellectual and Developmental Disabilities (I/DD) to physically present a blue envelope to officers during traffic stops in order to improve outcomes; H.R. 6605 (Vasquez, D-NM) the Secure Our Skies Drone Safety Act, which would require the Government Accountability Office to submit reports to Congress on the use of drone and counter-drone systems by law enforcement agencies and to submit recommendations on which policies should be changed to ensure law enforcement agencies can properly counter these threats; H.R. 6683 (Williams, R-TX) the Safer Schools Act, which would by creating two pilot grant programs for public schools within the U.S. Department of Justice (DOJ); H.R. 6911 (Harrigan, R-NC) the COPS Anti-Organized Crime and Cartel Enforcement Act, which would establish a new grant program to be administered by the Office of Community Oriented Policing Services (COPS) that would provide resources for State and local law enforcement agencies to create and equip specialized units dedicated to combatting organized crime, cartel operations, and transnational criminal organizations (TCOs). H.R. 7033 (Goldman, D-NY) the Federal Correctional Officer Paycheck Protection Act, which would establish a 35% increase to the General Schedule base pay for all BOP correctional staff, including GS, GL, and custodial wage-grade employees. H.R. 7114 (Moore, R-NC) the No Bounties on Badges Act, which would offer a Federal reward to anyone who provides credible information leading to the prevention, arrest, or conviction of an individual offering bounties to intimidate, harm, or kill a law enforcement officer; H.R. 7184 (McDowell, R-NC) the Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, which would provide Federal prosecutors and law enforcement agencies with the authority to hold foreign entities accountable for intentionally importing pill presses and precursor chemicals for illicit drug manufacturing; H.R. 7718 (Weber, R-TX) the Officer John Barnes and Chief Michael Ansbro Public Safety Officers Benefits Program Expansion Act, which would improve the Public Safety Officers Benefits (PSOB) Program, ensuring that the men and women who serve our communities-and their families-receive timely and meaningful support when tragedy strikes; H.R. 7834 (Lee, R-FL) the Safe Cloud Storage Act, which establishes baseline security and data protection standards for cloud service providers that store sensitive government and law enforcement information; H.R. 7876 (Landsman, D-OH) the Secret Service-Local Law Enforcement Partnership Act, which would create an Extraordinary Protection Reimbursement Program that would authorize more than $61 million for law enforcement agencies that collaborate with the USSS. S. 83 (Cruz, R-TX), the Thin Blue Line Act, which would provide that the murder of local or State prosecutors, law enforcement officers, or other public safety officers also be considered an aggravating factor in a Federal case; S. 122 (Banks, R-ID) the Qualified Immunity Act, which would codify the existing qualified immunity doctrine as established and upheld by the U.S. Supreme Court for decades; S. 146 (Cruz, R-TX) the Tools to Address Known Exploitation by Immobilizing Technological Deepfakes on Websites and Network (TAKE IT DOWN) Act, which would clarify and expand agency authority to combat the distribution of exploitative deepfake technology; PRIORITY - S. 167 (Tillis, R-NC) the Protect and Serve Act, which would make it a Federal crime to target a law enforcement officer with an assault that results in serious bodily harm or death; S. 180 (Grassley R-IA) the Protecting First Responders from Secondary Exposure Act, which would allow State and local governments to purchase containment devices through the existing Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP); S. 237 (Klobuchar, D-MN) the Honoring Our Fallen Heroes Act, which would categorize duty-related cancer fatalities as a line of duty death under the Public Safety Officers Benefits (PSOB) program. S. 331 (Cassidy, R-LA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Controlled Substances Act. S. 516 (Klobuchar, D-MN) the Stopping Harmful Image Exploitation and Limiting Distribution (SHIELD) Act, which would prohibit the distribution of Non-Consensually Distributed Intimate Images (NDII) that loopholes in select States have thus far prevented; S. 666 (Gillibrand, D-NY) the First Responders Wellness Act, which would establish a national hotline for first responders through the U.S. Department of Health and Human Services (HHS); S. 678 (Cortez Masto, D-NV) the Invest to Protect Act, which would establish a grant program, administered by the Community Oriented Policing Services Office within the U.S. Department of Justice, that would be used for the training of officers from police departments and municipalities that employ fewer than 200 law enforcement officers; TOP PRIORITY - S. 679 (Kennedy, R-LA) the LEOSA Reform Act, which would amend the Law Enforcement Officers Safety Act (LEOSA) exempting qualified active and retired law enforcement officers from local and State prohibitions on the carriage of concealed firearms; S. 767 (Kelly, D-AZ) the High Intensity Drug Trafficking Areas (HIDTA) Act, which would increase the HIDTA programs budget by over $28 million to provide for the creation of new grant programs that would enhance fentanyl seizure operations and improve coordination between law enforcement agencies; S. 911 (Masto, D-NV) the Chief Herbert D. Proffitt Act, which would amend the PSOB Program to ensure that Chief Proffitts family, and any others in a similar situation, would be eligible to apply for the programs benefit; PRIORITY - S. 978 (Moody, R-FL) the Homes for Every Local Protector, Educator, and Responder (HELPER) Act, which would give law enforcement more opportunities to find homes they can afford on a public servants salary based on the VA home loan program; S. 1077 (Collins, R-ME) the District of Columbia Local Funds Act, which would restore the District of Columbias ability to implement its Fiscal Year 2025 budget; S. 1247 (Schmitt, R-MO) the Public Safety Officer Free Speech Act, which would clarify and protect the speech of a public safety employee by allowing them to take legal action against an employer who violates this right; S. 1283 (Hagerty, R-TN), the Innovate to De-Escalate Modernization Act, which would establish the term less-than-lethal projectile device in Federal statute to ensure that these devices are properly classified by the U.S. Department of Justice (DOJ) based on a new five step criteria; S. 1295 (Justice, R-WV) the Bureau of Prisons Security Check and Action against Narcotics (BOP SCAN) in Mail Act, which would require the Director of the Bureau of Prisons to develop and implement a strategy to interdict fentanyl and other synthetic drugs in the mail at Federal correctional facilities; S. 1300 (Cornyn, R-TX) the Project Safe Neighborhoods Grant Program Authorization Act, which would reauthorize critical funding and support for local law enforcement agencies and community organizations that help reduce violent crime and enhance public safety; S. 1316 (Peters, D-MI) the Strong Communities Act, which would establish a grant program for local law enforcement agencies to assist in recruiting officers from their own community; S. 1333 (Cornyn, R-TX) the Strengthening Child Exploitation Enforcement Act, which would close loopholes in Federal child abuse criminal statutes; S. 1401 (Kennedy, R-LA) the Targeting Child Predators Act, which would extend the time law enforcement can seek a court order to delay a subpoena notification from 90 to 180 days; S. 1409 (Cornyn, R-TX) the Public Safety Officer Concussions and Traumatic Brain Injury Health Act, which would establish concussion protocols for Law Enforcement Agencies. S. 1572 (Blackburn, R-TN) the Federal Carjacking Enforcement Act, which would update the Federal statute governing carjacking offenses to make it easier for prosecutors to bring charges; S. 1595 (Cornyn, R-TX), the Improving Police Critical Aid for Responding to Emergencies (CARE) Act, which would expand the existing U.S. Department of Justices Edward Byrne Memorial Justice Assistance Grant (Byrne-JAG) program to allow for the purchase of trauma kits; S.2200 (Gallego, D-AZ), the First Responders Emergency Assistance Act, which would establish additional grants through the Department of Homeland Security to law enforcement agencies to areas near the Northern and Southern border; S. 2400(Fetterman, D-PA) the Art Market Integrity Act, which would require art dealers and auction houses to implement robust anti-money laundering compliance measures. S. 3023 (Blackburn, R-TN) the Safe Cloud Storage Act, which would establish baseline security and data protection standards for cloud service providers that store sensitive government and law enforcement information; S. 3189 (Sheehy, R-MT) the Strengthening Resources for Our Schools (SROs) Act, which would mend existing law to offer a Federal income tax exemption on retirement pay for any officer or veteran who chooses to serve as a School Resource Officer; S.3366 (Cornyn, R-TX) the Back the Blue Act, which would improve protections for law enforcement officers by increasing the penalties for those who kill or assault law enforcement officers, judges, and other public safety officers.; S.3453 (Scott, R-FL) the No Bounties on Badges Act, which would offer a Federal reward to anyone who provides credible information leading to the prevention, arrest, or conviction of an individual offering bounties to intimidate, harm, or kill a law enforcement officer. S. 3626 (Shaheen, D-NH) the Federal Correctional Officer Paycheck Protection Act, which would establish a 35% increase to the General Schedule base pay for all BOP correctional staff, including GS, GL, and custodial wage-grade employees; S. 3801(Grassley, R-IA) the the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and enhance Federal laws to combat money laundering operations and restrict the ability of criminals to profit from their crimes; S. 3897 (Gillibrand, D-NY) the Officer John Barnes and Chief Michael Ansbro Public Safety Officers Benefits Program Expansion Act, which would improve the Public Safety Officers Benefits (PSOB) Program, ensuring that the men and women who serve our communities-and their families-receive timely and meaningful support when tragedy strikes; S. 4260 (Cornyn, R-TX) the Child Predators Accountability Act, which would refine statutory definitions to ensure that the law encompasses both active and passive involvement of minors in sexually explicit depictions when the offender intentionally includes a child.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"RET","general_issue_code_display":"Retirement","description":"H.R. 3226 (Garbarino, R-NY), the Law Enforcement Officers Equity Act, which would expand the definition of law enforcement officer as it applies to salary and retirement benefits so that all Federal law enforcement officers will have access to them.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"TOP PRIORITY - H.R. 1505 (Stauber, D-MN) the Public Safety Employer-Employee Cooperation Act, which would guarantee public safety officers the right to form and join unions and bargain collectively with their employers over wages, hours, and working conditions; TOP PRIORITY - S. 636 (Hickenlooper, D-CO) the Public Safety Employer-Employee Cooperation Act, which would guarantee public safety officers the right to form and join unions and bargain collectively with their employers over wages, hours, and working conditions;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"S. 1077 (Collins, R-ME) the District of Columbia Local Funds Act, which would restore the District of Columbias ability to implement its Fiscal Year 2025 budget;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 405 (Fulcher, R-ID) the Keep Every Extra Penny (KEEP) Act, which would eliminate income tax on a public servants overtime pay; H.R. 7210 (Fitzpatrick, R-PA) the Fuel the Force Act, which amends both the Internal Revenue Code of 1986 and the Higher Education Act of 1965 to provide $100,000 in annual Federal income tax exclusion to full-time law enforcement officers with at least five years of service; H.R. 7361 (Gooden, R-TX) the No Tax on Restored Benefits Act, which would exclude lump-sum payments originating from the Social Security Fairness Act from Federal taxes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"FIR","general_issue_code_display":"Firearms/Guns/Ammunition","description":"TOP PRIORITY - H.R. 2243 (Bacon, R-NE) the LEOSA Reform Act, which would amend the Law Enforcement Officers Safety Act (LEOSA) exempting qualified active and retired law enforcement officers from local and State prohibitions on the carriage of concealed firearms; H.R. 2255 (Fry, R-SC) the Federal Law Enforcement Service Weapon Purchase Act, which would allow Federal law enforcement officers to purchase retired service weapons;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 1410 (Garbarino, R-NY) the 9/11 Responder and Survivor Health Funding Correction Act, which addresses the impending funding shortfall facing the World Trade Center Health Program (WTCHP); H.R. 3327 (Bacon, R-NE) the Public Safety Retirees Healthcare Protection Act, which would update the Healthcare Enhancement for Local Public Safety (HELPS) Retirees Act in current Federal law; H.R. 6147 (Landsman, D-OH) the Expanding Health Care Options for First Responders Act, which would give law enforcement and other public safety professionals the option to buy into Medicare at the age of 50; S. 739 (Gillibrand, D-NY), the 9/11 Responder and Survivor Health Funding Correction Act, which addresses the impending funding shortfall facing the World Trade Center Health Program (WTCHP); S. 3221 (Gallego, D-AZ) the Expanding Health Care Options for First Responders Act, which would give law enforcement and other public safety professionals the option to buy into Medicare at the age of 50;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42835,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"O","last_name":"PASCO","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":44703,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"M","last_name":"RICHARDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107311,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"TABOH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146414,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147974,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"GORMALLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ffa88e50-9459-4df5-a323-7360719ad7ae/","filing_uuid":"ffa88e50-9459-4df5-a323-7360719ad7ae","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ffa88e50-9459-4df5-a323-7360719ad7ae/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-07-16T20:52:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cd8cbe49-569a-4b7a-b4d9-35a57eafeba2/","filing_uuid":"cd8cbe49-569a-4b7a-b4d9-35a57eafeba2","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cd8cbe49-569a-4b7a-b4d9-35a57eafeba2/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Scott Frey","dt_posted":"2026-07-16T21:11:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2033 K Street NW","registrant_address_2":"Suite 450","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401010854,"url":"https://lda.gov/api/v1/registrants/401010854/","house_registrant_id":42171,"name":"ALLIANCE FOR AGING RESEARCH","description":"Non-profit healthcare advocacy organization","address_1":"2033 K Street NW","address_2":"Suite 450","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SCOTT FREY","contact_telephone":"+1 571-289-1385","dt_updated":"2026-09-24T12:38:43.419803-04:00"},"client":{"id":196811,"url":"https://lda.gov/api/v1/clients/196811/","client_id":12,"name":"ALLIANCE FOR AGING RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-04"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"-FY27 report language for the Food and Drug Administration on antipsychotics black box warning -FY27 report language for the Medicare Program antipsychotics measure -FY27 report language for the Medicare Prescription Payment Plan -FY27 report language for utilization management reform in the Medicare program -FY27 medical research funding -FY27 funding for FDA's Neurology Drug Program -FY 27 Appropriations H.R. 9260 and pending Senate bill, Increase Funding for Programs benefitting older adults at HHS, including ASPE, NIH, CDC HRSA, ARHQ, FDA, CMS, ACL","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program and its impact on older adults -Utilization management reform in Medicare -Increasing Medication Access for Seniors Act (H.R.6401) -End Coverage with Evidence Development for Alzheimer's Medications and TAVR","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138576,"prefix":"ms","prefix_display":"MS.","first_name":"ADINA","nickname":null,"middle_name":"ROSE","last_name":"LASSER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149533,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"FREY","suffix":null,"suffix_display":null},"covered_position":"Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4150fb21-6764-4629-a6d9-ed58dd4a4200/","filing_uuid":"4150fb21-6764-4629-a6d9-ed58dd4a4200","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/4150fb21-6764-4629-a6d9-ed58dd4a4200/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael DeRose","dt_posted":"2026-07-17T10:20:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"Grand Central Station, PO Box 4777","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10163","registrant":{"id":401104060,"url":"https://lda.gov/api/v1/registrants/401104060/","house_registrant_id":null,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","description":"Parkinson's disease research","address_1":"Grand Central Station, PO Box 4777","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10163","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL DEROSE","contact_telephone":"+1 212-509-0995","dt_updated":"2026-07-23T15:55:48.243467-04:00"},"client":{"id":200707,"url":"https://lda.gov/api/v1/clients/200707/","client_id":12,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, and beneficiary protections.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Federal funding for Parkinsons disease and neurodegenerative disease research, care, and public health programs in Fiscal Year (FY) 2027 appropriations legislation including H.R. 9260 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, H.R. 8469 Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes, H.R. 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027, and other appropriations legislation. Advocacy related to funding levels, report language, and congressional appropriations requests. Support overall funding increases for medical research and neurological condition research across NIH, ARPA-A, DOD, and VA. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy for appropriations to support implementation of the National Parkinsons Project (NPP), advisory council activities, and related reporting requirements consistent with enacted appropriations language. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations for Parkinsons disease and related conditions across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)), and increasing investment for neurological disease research such as the BRAIN Initiative. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy for appropriations and related report language to expand the Udall Centers. Advanced Research Projects Agency for Health (ARPA-H), including advocacy for report language directing prioritization of neurodegenerative disease research and alignment with emerging opportunities in chronic disease and aging research. Department of Health and Human Services (HHS) environmental risk and prevention efforts, including advocacy for report language and appropriations to support interagency coordination and research on toxic exposures and neurodegenerative disease prevention. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research funding, including advocacy for report language to expand eligibility to Parkinsons disease and related dementias. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support surveillance and data collection on Parkinsons disease and related conditions. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program (TERP) to support research on Parkinsons disease and service-related exposures. Department of Veterans Affairs (VA) Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Neurology Centers of Excellence, including advocacy for increased appropriations and report language to support research, clinical care, and access for veterans living with Parkinsons disease. Department of Veterans Affairs (VA) Office of Research and Development (ORD), including advocacy for report language to increase focus on Parkinsons disease and related conditions within VAs medical research portfolio. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), including advocacy for appropriations and report language supporting research on toxic exposures and Parkinsons disease. Food and Drug Administration (FDA) neurodegenerative disease guidance and reporting, including advocacy for report language to improve coordination, transparency, and disease-specific guidance for Parkinsons disease and related conditions. Food and Drug Administration (FDA) Neurology Drug Program to coordinate efforts on central nervous system drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug affordability and access for individuals with Parkinsons disease and other chronic conditions, including advocacy related to patient access to medications, cost-sharing, and barriers to accessing clinically appropriate medications. Prescription drug coverage and access under Medicare, including advocacy related to policies impacting access to Parkinsons disease treatments, formulary placement, and utilization management.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical research, clinical care, and access to services for veterans living with Parkinsons disease and other neurological conditions, including advocacy related to programs, research, and exposure-related risk factors within the Department of Veterans Affairs (VA) and Department of Defense (DOD). Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Department of Veterans Affairs (VA) Neurology Centers of Excellence, including advocacy for appropriations and report language to support specialized care, research, and access to services for veterans living with Parkinsons disease. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program to support research on Parkinsons disease and service-related exposures. Research on service-related exposures and Parkinsons disease, including advocacy related to toxic exposures, traumatic brain injury, and other risk factors associated with military service and increased risk of neurodegenerative disease. The Boxing Therapy for Parkinsons Access Act (H.R. 9150), including advocacy related to requiring the VA to furnish boxing-based exercise classes to veterans who are enrolled in the VA health care system, have been diagnosed with \"\"Parkinson's disease or a similar movement disorder\"\", and specifically elect to participate in such classes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Environmental exposures and toxic substances linked to Parkinsons disease, including advocacy related to reducing or eliminating exposure to chemicals such as paraquat and other environmental contaminants associated with increased risk of neurodegenerative disease. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax policy related to financial support for family caregivers and individuals with chronic conditions, including advocacy to reduce out-of-pocket costs and improve affordability of care. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Credit for Caring Act of 2025 (S. 925 / H.R. 2036), including advocacy related to providing a nonrefundable tax credit to offset caregiving expenses for working family caregivers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4150fb21-6764-4629-a6d9-ed58dd4a4200/","filing_uuid":"4150fb21-6764-4629-a6d9-ed58dd4a4200","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/4150fb21-6764-4629-a6d9-ed58dd4a4200/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael DeRose","dt_posted":"2026-07-17T10:20:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"Grand Central Station, PO Box 4777","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10163","registrant":{"id":401104060,"url":"https://lda.gov/api/v1/registrants/401104060/","house_registrant_id":null,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","description":"Parkinson's disease research","address_1":"Grand Central Station, PO Box 4777","address_2":null,"address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10163","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL DEROSE","contact_telephone":"+1 212-509-0995","dt_updated":"2026-07-23T15:55:48.243467-04:00"},"client":{"id":200707,"url":"https://lda.gov/api/v1/clients/200707/","client_id":12,"name":"THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, and beneficiary protections.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Federal funding for Parkinsons disease and neurodegenerative disease research, care, and public health programs in Fiscal Year (FY) 2027 appropriations legislation including H.R. 9260 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, H.R. 8469 Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes, H.R. 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027, and other appropriations legislation. Advocacy related to funding levels, report language, and congressional appropriations requests. Support overall funding increases for medical research and neurological condition research across NIH, ARPA-A, DOD, and VA. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy for appropriations to support implementation of the National Parkinsons Project (NPP), advisory council activities, and related reporting requirements consistent with enacted appropriations language. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations for Parkinsons disease and related conditions across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)), and increasing investment for neurological disease research such as the BRAIN Initiative. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy for appropriations and related report language to expand the Udall Centers. Advanced Research Projects Agency for Health (ARPA-H), including advocacy for report language directing prioritization of neurodegenerative disease research and alignment with emerging opportunities in chronic disease and aging research. Department of Health and Human Services (HHS) environmental risk and prevention efforts, including advocacy for report language and appropriations to support interagency coordination and research on toxic exposures and neurodegenerative disease prevention. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research funding, including advocacy for report language to expand eligibility to Parkinsons disease and related dementias. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support surveillance and data collection on Parkinsons disease and related conditions. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program (TERP) to support research on Parkinsons disease and service-related exposures. Department of Veterans Affairs (VA) Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Neurology Centers of Excellence, including advocacy for increased appropriations and report language to support research, clinical care, and access for veterans living with Parkinsons disease. Department of Veterans Affairs (VA) Office of Research and Development (ORD), including advocacy for report language to increase focus on Parkinsons disease and related conditions within VAs medical research portfolio. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), including advocacy for appropriations and report language supporting research on toxic exposures and Parkinsons disease. Food and Drug Administration (FDA) neurodegenerative disease guidance and reporting, including advocacy for report language to improve coordination, transparency, and disease-specific guidance for Parkinsons disease and related conditions. Food and Drug Administration (FDA) Neurology Drug Program to coordinate efforts on central nervous system drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug affordability and access for individuals with Parkinsons disease and other chronic conditions, including advocacy related to patient access to medications, cost-sharing, and barriers to accessing clinically appropriate medications. Prescription drug coverage and access under Medicare, including advocacy related to policies impacting access to Parkinsons disease treatments, formulary placement, and utilization management.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical research, clinical care, and access to services for veterans living with Parkinsons disease and other neurological conditions, including advocacy related to programs, research, and exposure-related risk factors within the Department of Veterans Affairs (VA) and Department of Defense (DOD). Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) and Department of Veterans Affairs (VA) Neurology Centers of Excellence, including advocacy for appropriations and report language to support specialized care, research, and access to services for veterans living with Parkinsons disease. Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), including advocacy for funding for the Parkinsons Research Program (PRP) and the Toxic Exposure Research Program to support research on Parkinsons disease and service-related exposures. Research on service-related exposures and Parkinsons disease, including advocacy related to toxic exposures, traumatic brain injury, and other risk factors associated with military service and increased risk of neurodegenerative disease. The Boxing Therapy for Parkinsons Access Act (H.R. 9150), including advocacy related to requiring the VA to furnish boxing-based exercise classes to veterans who are enrolled in the VA health care system, have been diagnosed with \"\"Parkinson's disease or a similar movement disorder\"\", and specifically elect to participate in such classes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Environmental exposures and toxic substances linked to Parkinsons disease, including advocacy related to reducing or eliminating exposure to chemicals such as paraquat and other environmental contaminants associated with increased risk of neurodegenerative disease. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":118859,"prefix":null,"prefix_display":null,"first_name":"MASON","nickname":null,"middle_name":null,"last_name":"ZEAGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false},{"lobbyist":{"id":143116,"prefix":null,"prefix_display":null,"first_name":"SALLIE","nickname":null,"middle_name":"JAMES","last_name":"WEART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax policy related to financial support for family caregivers and individuals with chronic conditions, including advocacy to reduce out-of-pocket costs and improve affordability of care. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Credit for Caring Act of 2025 (S. 925 / H.R. 2036), including advocacy related to providing a nonrefundable tax credit to offset caregiving expenses for working family caregivers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143739,"prefix":"mr","prefix_display":"MR.","first_name":"DREW","nickname":null,"middle_name":"CHARLES","last_name":"HATTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151814,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"MUTONE-SMITH","suffix":null,"suffix_display":null},"covered_position":"USAID - Senior Policy and Program Officer, USAID - Policy Team Leader, USAID - Division Chief for Policy, Partnerships, Programs & Communications, USAID - Senior Policy Advisor, USAID - Managing Director","new":false},{"lobbyist":{"id":151815,"prefix":null,"prefix_display":null,"first_name":"GRANT","nickname":null,"middle_name":null,"last_name":"COPE","suffix":null,"suffix_display":null},"covered_position":"Senate Environment and Public Works Committee - Senior Counselor, EPA - Senior Counselor to the Administrator","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/adf7cf04-82a6-416b-b3ab-b2ac1f8bfd51/","filing_uuid":"adf7cf04-82a6-416b-b3ab-b2ac1f8bfd51","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/adf7cf04-82a6-416b-b3ab-b2ac1f8bfd51/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Debra M. Bryant","dt_posted":"2026-07-17T15:20:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"905 Cedarhurst Drive","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Raleigh","registrant_state":"NC","registrant_zip":"27609","registrant":{"id":401103156,"url":"https://lda.gov/api/v1/registrants/401103156/","house_registrant_id":null,"name":"UNIFIED SOLUTIONS, LLC","description":"Consulting Firm","address_1":"905 Cedarhurst Drive","address_2":null,"address_3":null,"address_4":null,"city":"Raleigh","state":"NC","state_display":"North Carolina","zip":"27609","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DEBRA M. BRYANT","contact_telephone":"+1 202-263-9902","dt_updated":"2026-07-17T16:17:23.473183-04:00"},"client":{"id":198039,"url":"https://lda.gov/api/v1/clients/198039/","client_id":51,"name":"GENERAL FEDERATION OF WOMEN'S CLUBS","general_description":"Women's Volunteer Service Organization","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-09-02"},"lobbying_activities":[{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Take It Down Act, HR 633, S. 146; Trafficking Survivors Relief Act, HR 1379; Crime Victims Fund Stabilization Act of 2025, HR 909; Kids Online Safety Act, S. 1748; Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2025, H.R. 1144; Guidelines for User Age-Verification and Responsible Dialogue Act (GUARD Act), S. 3062","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59583,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":"MARTIN","last_name":"BRYANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2026 Commerce, Justice, Science and Related Agencies Appropriations Bill, HR 6938; FY 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill; FY 2026 National Security, Department of State, and Related Programs Appropriations Bill, HR 7006; FY 2027 Commerce, Justice, Science and Related Agencies Appropriations Bill; FY 2027 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill; FY 2027 National Security, Department of State, and Related Programs Appropriations Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59583,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":"MARTIN","last_name":"BRYANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"PREEMIE Reauthorization Act, HR 1197, S 1562; Preventing Maternal Deaths Reauthorization Act, HR 1909, S 2621; Alzheimer's Screening and Prevention Act, HR 6130, S. 3267; Accelerating Access to Dementia and Alzheimer's Provider Training Act, HR 3747, S. 4036","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59583,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":"MARTIN","last_name":"BRYANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Library Services and Technology Act, Institute of Museum and Library Services","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59583,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":"MARTIN","last_name":"BRYANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/469f381c-dacc-4e3d-a8dc-423aea445190/","filing_uuid":"469f381c-dacc-4e3d-a8dc-423aea445190","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/469f381c-dacc-4e3d-a8dc-423aea445190/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Carol Ann Schwartz, Hadassah National President","dt_posted":"2026-07-20T11:11:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"40 WALL STREET","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW YORK","registrant_state":"NY","registrant_zip":"10005","registrant":{"id":52925,"url":"https://lda.gov/api/v1/registrants/52925/","house_registrant_id":34920,"name":"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.","description":"NON-PROFIT ORGANIZATION","address_1":"40 WALL STREET","address_2":null,"address_3":null,"address_4":null,"city":"NEW YORK","state":"NY","state_display":"New York","zip":"10005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROL ANN SCHWARTZ","contact_telephone":"+1 513-271-7600","dt_updated":"2026-07-17T10:37:20.309443-04:00"},"client":{"id":157951,"url":"https://lda.gov/api/v1/clients/157951/","client_id":12,"name":"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-01"},"lobbying_activities":[{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"HR 661 - MIRACLE Medical Technology Act of 2025 All provisions This bill requires the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services. H.R. 764/S. 280 - Global Health, Empowerment and Rights Act All provisions This bill prohibits determining ineligibility of foreign nongovernmental organizations to receive assistance solely on the basis of health or medical services, including counseling and referral services, provided by such organizations with non-United States Government funds if such services do not violate the laws of the country in which they are being provided. H.R. 1229/S. 554 - United States-Israel Defense Partnership Act of 2025 All provisions This bill enhances bilateral defense cooperation between the United States and Israel. H.R. 2439/S. 3393 - Support UNFPA Funding Act All provisions This bill authorizes contributions to the United Nations Population Fund. H.R. 2609 - PEACE Act All provisions This bill promotes education and training to United States diplomatic personnel relating to the Abraham Accords and other normalization agreements with Israel. H.R. 4473 - BIRD Health Act of 2025 All provisions This bill directs the Secretary of Health and Human Services to establish a bilateral research and innovation program to facilitate and coordinate efforts between the United States and Israel in certain health-related areas. H.R. 4655 - United States-Israel PTSD Collaborative Research Act All provisions This bill directs the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel. H. Res. 525 - Affirming the role of the United States in eliminating sexual violence in conflict. All provisions This resolution affirms the role of the United States in eliminating sexual violence in conflict. S. Res. 410 - A resolution calling on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. All provisions This resolution calls on the President to recognize a demilitarized State of Palestine, as consistent with international law and the principles of a two-state solution, alongside a secure State of Israel. S. J. Res. 32, S. J. Res. 138 - A joint resolution providing for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. All provisions. These resolutions provide for congressional disapproval of the proposed licensing of certain defense articles and services to Israel. H.R. 7018/S. 1521 - Stand with Israel Act of 2026 All provisions. This bill limits funding for United States participation in the United Nations if Israel is illegally expelled. H.R. 7540/S. 3855 - United States-Israel FUTURES Act of 2026 All provisions. This bill enhances bilateral defense cooperation between the United States and Israel. NEW: H.R. 9322/S. 4219 - Abraham Accords Defense Cooperation Act of 2026 All provisions This bill would require the Secretary of Defense to establish an initiative to bolster defense cooperation with Abraham Accords countries. H.R. 9147 - Abraham Accords Expansion Act of 2026 All provisions This bill supports efforts to expand the Abraham Accords to additional countries, including those in Central Asia and the Caucasus, and establish a special envoy in the US government to further advance peace and integration. S. 4681 - Optimizing Acquisition Strategies for Integrated Security (OASIS) in the Middle East Act All provisions This bill requires the Department of Defense to develop a coordinated air and missile defense acquisition strategy with Israel and Abraham Accords partners.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 768/S. 332 - Holocaust Education and Antisemitism Lessons Act All provisions This bill directs the U.S. Holocaust Memorial Museum to study and report on Holocaust education efforts in states, local educational agencies (LEAs), and public elementary and secondary schools. H.R. 5714 - October 7 Remembrance Education Act All provisions. This bill directs the United States Holocaust Memorial Museum to develop a curriculum for the study of antisemitism surrounding Hamas October 7, 2023, terrorist attacks against Israel.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"H.R. 5645/S. 2947 - Pray Safe Act of 2025 All provisions. This bill establishes the Federal Clearinghouse on Safety and Best Practices for Nonprofit Organizations, Faith-based Organizations, and Houses of Worship within the Department of Homeland Security. H.R. 9211/S. 4576 - Jewish American Security Act All provisions, including Section Five that would increase federal funding for the Nonprofit Security Grant Program to $1 billion.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"H.R. 1007/S. 558 Antisemitism Awareness Act of 2025 All provisions This bill provides for the consideration of a definition of antisemitism set forth by the International Holocaust Remembrance Alliance for the enforcement of Federal antidiscrimination laws concerning education programs or activities, and for other purposes. H.R. 15/S. 1503 - Equality Act All provisions This bill prohibits discrimination on the basis of sex, gender identity, and sexual orientation. H.R. 3691 - Commission to Study Acts of Antisemitism in the United States Act All provisions This bill establishes the Commission to Study Acts of Antisemitism in the United States to investigate the causes of antisemitism and provide policy recommendations to Congress and the President. H.R. 6857/S. 163 - Protecting Students on Campus Act of 2025 All provisions This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964. H.R. 8239 - SACRED Act All provisions This bill amends title 18, United States Code, to prohibit harassment of persons, within a distance of 100 feet or closer to such place of religious worship. H. Res. 1251 - Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community. S. Res. 738 - Recognizing the significance of Jewish American Heritage Month and calling on elected officials and civil society leaders to counter antisemitism. All provisions. These resolutions recognize May 2026 as Jewish American Heritage Month and call on elected officials and civil society leaders to counter antisemitism. H.R. 9211/S. 4576 - Jewish American Security Act All provisions, including Section 4 that would increase protection for Jewish students civil rights by establishing a Title VI coordinator at the Department of Education to address antisemitism, increase funding for the Nonprofit Security Grant Program to $1 billion, and assess violent antisemitism and document and respond to antisemitic content on social media platforms.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. H.R. 7694 - Gwenns Law All provisions This bill directs the Department of Health and Human Services to carry out a public awareness campaign to improve womens participation in clinical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FAM","general_issue_code_display":"Family issues/Abortion/Adoption","description":"H.R. 999/S. 422 - Right to Contraception Act All provisions This bill would safeguard Americans right to access all forms of birth control and protect against federal and state efforts to restrict it. H.R. 1197/S. 1562 - PREEMIE Reauthorization Act of 2025 All provisions This bill reauthorizes the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act through FY2029 and establishes actions by the Department of Health and Human Services (HHS) to address preterm birth (i.e., babies born before 37 weeks of pregnancy). The bill was enacted on February 2, 2026. H.R. 1878 - IVF Access and Affordability Act All provisions This bill introduces a tax credit for fertility treatments, capping at $20,000 annually, with provisions for joint filers, income-based reductions, and a five-year carryforward for unused credits, effective for taxable years post-enactment. H.R. 2049 - Access to Family Building Act All provisions This bill provides a statutory right to access assisted reproductive technology (e.g., in vitro fertilization). R. 2762/S. 1394 Expanding Access to Family Planning Act All provisions This bill provides enhanced funding for family planning services. S. 2035 Protect IVF Act All provisions This bill establishes statutory rights to choose to receive, provide, and cover fertility treatments. H.R. 12 - Womens Health Protection Act of 2025 All provisions This bill protects a persons ability to determine whether to continue or end a pregnancy, and to protect a health care providers ability to provide abortion services. H.R. 4888/S. 2671 - Reproductive Rights are Human Rights Act of 2025 All provisions This bill will amend the Foreign Assistance Act of 1961 to require a section on reproductive rights in the Annual Country Reports on Human Rights Practices. H.R. 4977/S. 141 - Connected MOM Act All provisions This bill identifies and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women. H.R. 6945 - Supporting Pregnant and Parenting Women and Families Act All provisions This bill amends part A of title IV of the Social Security Act to clarify the authority of States to use funds for pregnancy centers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 9310 - Department of Homeland Security Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027 Provisions for increased funding and staff for the Office of the Special Envoy to Monitor and Combat Antisemitism for FY 2027; funding for the Special Envoy for Holocaust Issues; increasing the authorized funding for the Nonprofit Security Grant Program; security and defense partnerships with Israel including US-Israel missile defense cooperation on Iron Dome and Davids Sling and Arrow defense systems; US-Israel Anti-Tunneling Cooperation; access to essential health care, including abortion, contraception, fertility, and gender-affirming medical care. These bills make appropriations for the fiscal year ending September 30, 2027. H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 Provisions for increased funding for US-Israel and US-Abraham Accords partners cooperative programs; provisions to strengthen defense and defense technology cooperation; provisions to monitor and combat antisemitism. This bill authorizes appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"H.R. 5011 - Violent Antisemitism Threat Assessment Act All provisions This bill will require a report from the Secretary of Defense to the House and Senate Committees on Armed Services on the threat posed by violent antisemitism as a component of transnational extremist movements. H.R. 5681 - STOP HATE Act of 2025 All provisions. This bill requires the reporting of certain terms of service of social media companies for purposes of limiting the online presence of terrorist organizations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"H.R. 8119 - HOPE with Fertility Services Act All provisions. This bill requires group health plans that cover obstetrical services to also cover infertility diagnosis, treatment, and standard fertility preservation services. H.R. 1670/S. 797 - Family Building FEHB Fairness Act All provisions This bill adds a requirement for Federal employee health benefit plans to include assisted reproductive treatment benefits. H.R. 2557/S. 1231 - IVF for Military Families Act All provisions This bill amends title 10, United States Code, to provide fertility treatment under the TRICARE Program. H.R. 4611/S. 2377 - EACH Act of 2025 All provisions This bill aims to ensure affordable abortion coverage and care for every person. H.R. 4648/S. 2408 - Access to Fertility Treatment and Care Act All provisions This bill will require health insurance plans to provide coverage for fertility treatment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"H.R. 2588/S. 3724 - Improving Reporting to Prevent Hate Act of 2025 All provisions. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to include certain reporting to the uniform crime reporting program. H.R. 9066 - Community-Based Approaches to Prevent and Address Hate Crimes Act of 2026All provisions This bill would authorize grant funding through the Department of Justice (DOJ) to support community organizations working to prevent and respond to hate crimes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142945,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115818,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"GURSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138095,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/70b13372-e80d-4fdb-b6b9-5ac9a5fc779d/","filing_uuid":"70b13372-e80d-4fdb-b6b9-5ac9a5fc779d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/70b13372-e80d-4fdb-b6b9-5ac9a5fc779d/print/","filing_document_content_type":"text/html","income":null,"expenses":"140000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"David Bergman","dt_posted":"2026-07-20T11:11:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7700 Old Georgetown Road, Suite 250","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Bethesda","registrant_state":"MD","registrant_zip":"20814","registrant":{"id":1546,"url":"https://lda.gov/api/v1/registrants/1546/","house_registrant_id":30523,"name":"AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE","description":null,"address_1":"7700 Old Georgetown Road","address_2":"Suite 250","address_3":null,"address_4":null,"city":"Bethesda","state":"MD","state_display":"Maryland","zip":"20814","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID BERGMAN","contact_telephone":"+1 703-801-5518","dt_updated":"2026-07-09T16:12:43.740732-04:00"},"client":{"id":102625,"url":"https://lda.gov/api/v1/clients/102625/","client_id":12,"name":"AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Dr. Lorna Breen Health Care Provider Protection Act (H.R 929, S. 266) Rural Physician Workforce Production Act (H.R. 1153) Physicians for Underserved Areas Act (H.R. 870, S. 1044) Fair Access In Residency Act (H.R. 2314, S.2715) Teaching Health Center Graduate Medical Education National Institutes of Health Research Expanding Medical Education Act (H.R. 2106, S. 975) Community TEAMS Act (H.R. 3885, S.3989) Post GRAD Act (H.R. 3711) Rural Health Transformation Program Healthcare Advisory Council Resident Physician Shortage Reduction Act (H.R.4731/S.2439) Medical Student Education Authorization Act (H.R.5248) Resident Education Deferred Interest (REDI Act) (H.R. 2028, S. 942) Rural Residency Planning and Development Act of 2025 (H.R. 6468) PSLF Payment Completion Fairness Act (H.R. 3267, S.3487) Foreign Medical School Accountability Fairness Act (S. 3757) Nutrition Education Community Academic Health Systems Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026 (H.R. 9389)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154445,"prefix":null,"prefix_display":null,"first_name":"SAMHITA","nickname":null,"middle_name":null,"last_name":"SUBRAMANIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Student Financial Aid Financial value transparency and gainful employment Artificial Intelligence Institutional risk sharing and accountability Public Service Loan Forgiveness Program Accreditation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154445,"prefix":null,"prefix_display":null,"first_name":"SAMHITA","nickname":null,"middle_name":null,"last_name":"SUBRAMANIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill Osteopathic Research and Representation FY27 Budget and Appropriations Community Academic Health Systems Osteopathic Manipulative Treatment Public Health Service Act Title VII and Title VIII Health Professions Workforce Programs Childrens Hospital Graduate Medical Education Program Teaching Health Center Graduate Medical Education Program National Health Service Corps Scholarship and Loan Programs Health Care Workforce Innovation Program Rural Residency Planning and Development Program Medicare Payment Advisory Commission (MedPAC)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154445,"prefix":null,"prefix_display":null,"first_name":"SAMHITA","nickname":null,"middle_name":null,"last_name":"SUBRAMANIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":32,"name":"Education, Dept of"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"VA Medical Research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154445,"prefix":null,"prefix_display":null,"first_name":"SAMHITA","nickname":null,"middle_name":null,"last_name":"SUBRAMANIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"FY27 NDAA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":119625,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107296,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"PYATT","last_name":"CROCKETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139663,"prefix":"mr","prefix_display":"MR.","first_name":"TREY","nickname":null,"middle_name":"CHARLES","last_name":"HINES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143787,"prefix":"mr","prefix_display":"MR.","first_name":"LUCA","nickname":null,"middle_name":"JOSEPH","last_name":"CELLUCCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98684,"prefix":null,"prefix_display":null,"first_name":"SHEILA","nickname":null,"middle_name":null,"last_name":"DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154445,"prefix":null,"prefix_display":null,"first_name":"SAMHITA","nickname":null,"middle_name":null,"last_name":"SUBRAMANIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149480,"prefix":null,"prefix_display":null,"first_name":"LILLIAN","nickname":null,"middle_name":null,"last_name":"ANDEMICAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c83c3734-d6c4-482b-be31-2f4e3a9ed826/","filing_uuid":"c83c3734-d6c4-482b-be31-2f4e3a9ed826","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c83c3734-d6c4-482b-be31-2f4e3a9ed826/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey Miller","dt_posted":"2026-07-20T11:11:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P.O. Box 625","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Buda","registrant_state":"TX","registrant_zip":"78610","registrant":{"id":401104313,"url":"https://lda.gov/api/v1/registrants/401104313/","house_registrant_id":null,"name":"MILLER STRATEGIES, LLC","description":"strategic public affairs","address_1":"P.O. Box 625","address_2":null,"address_3":null,"address_4":null,"city":"Buda","state":"TX","state_display":"Texas","zip":"78610","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY MILLER","contact_telephone":"+1 202-434-8242","dt_updated":"2026-07-30T15:40:39.312430-04:00"},"client":{"id":73257,"url":"https://lda.gov/api/v1/clients/73257/","client_id":73257,"name":"ALZHEIMER'S ASSOCIATION","general_description":"Association leading the way to end Alzheimers and other dementia with global research","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-04-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":"Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.","new":true},{"lobbyist":{"id":149196,"prefix":null,"prefix_display":null,"first_name":"STEFAN","nickname":null,"middle_name":null,"last_name":"PASSANTINO","suffix":null,"suffix_display":null},"covered_position":"Deputy White House Counsel from January 2017 through September, 2018","new":true},{"lobbyist":{"id":152217,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Assistant, and Legislative Correspondent for Rep. Kevin McCarthy; Intern at Committee on Ways and Means; Intern at the White House.","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":"Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.","new":true},{"lobbyist":{"id":149196,"prefix":null,"prefix_display":null,"first_name":"STEFAN","nickname":null,"middle_name":null,"last_name":"PASSANTINO","suffix":null,"suffix_display":null},"covered_position":"Deputy White House Counsel from January 2017 through September, 2018","new":true},{"lobbyist":{"id":152217,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Assistant, and Legislative Correspondent for Rep. Kevin McCarthy; Intern at Committee on Ways and Means; Intern at the White House.","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c83c3734-d6c4-482b-be31-2f4e3a9ed826/","filing_uuid":"c83c3734-d6c4-482b-be31-2f4e3a9ed826","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c83c3734-d6c4-482b-be31-2f4e3a9ed826/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey Miller","dt_posted":"2026-07-20T11:11:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P.O. Box 625","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Buda","registrant_state":"TX","registrant_zip":"78610","registrant":{"id":401104313,"url":"https://lda.gov/api/v1/registrants/401104313/","house_registrant_id":null,"name":"MILLER STRATEGIES, LLC","description":"strategic public affairs","address_1":"P.O. Box 625","address_2":null,"address_3":null,"address_4":null,"city":"Buda","state":"TX","state_display":"Texas","zip":"78610","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY MILLER","contact_telephone":"+1 202-434-8242","dt_updated":"2026-07-30T15:40:39.312430-04:00"},"client":{"id":73257,"url":"https://lda.gov/api/v1/clients/73257/","client_id":73257,"name":"ALZHEIMER'S ASSOCIATION","general_description":"Association leading the way to end Alzheimers and other dementia with global research","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-04-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":"Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.","new":true},{"lobbyist":{"id":149196,"prefix":null,"prefix_display":null,"first_name":"STEFAN","nickname":null,"middle_name":null,"last_name":"PASSANTINO","suffix":null,"suffix_display":null},"covered_position":"Deputy White House Counsel from January 2017 through September, 2018","new":true},{"lobbyist":{"id":152217,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Assistant, and Legislative Correspondent for Rep. Kevin McCarthy; Intern at Committee on Ways and Means; Intern at the White House.","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":"Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.","new":true},{"lobbyist":{"id":149196,"prefix":null,"prefix_display":null,"first_name":"STEFAN","nickname":null,"middle_name":null,"last_name":"PASSANTINO","suffix":null,"suffix_display":null},"covered_position":"Deputy White House Counsel from January 2017 through September, 2018","new":true},{"lobbyist":{"id":152217,"prefix":null,"prefix_display":null,"first_name":"SHANE","nickname":null,"middle_name":null,"last_name":"ROSE","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Assistant, and Legislative Correspondent for Rep. Kevin McCarthy; Intern at Committee on Ways and Means; Intern at the White House.","new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a8efa44d-37e9-4224-ab4f-baf4c2c2f9aa/","filing_uuid":"a8efa44d-37e9-4224-ab4f-baf4c2c2f9aa","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/a8efa44d-37e9-4224-ab4f-baf4c2c2f9aa/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"M'liss Reingruber","dt_posted":"2026-07-20T11:51:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5614 Connecticut Ave NW #288","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20015","registrant":{"id":401105571,"url":"https://lda.gov/api/v1/registrants/401105571/","house_registrant_id":null,"name":"USAGAINSTALZHEIMERS ACTION","description":"Advocacy organization","address_1":"5614 Connecticut Ave NW #288","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20015","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"M'LISS REINGRUBER","contact_telephone":"+1 202-349-3803","dt_updated":"2026-07-22T10:55:30.938145-04:00"},"client":{"id":206248,"url":"https://lda.gov/api/v1/clients/206248/","client_id":12,"name":"USAGAINSTALZHEIMERS ACTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-07-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4632 - Lankford-Hassan Prevent Government Shutdowns Act of 2026; Issues related to funding for NIH; Issues related to funding for CDC; Issues related to funding for CMS; Issues related to funding for Alzheimer's","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Durbin Cures Act; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 247, S. 46 - Health Care Affordability Act of 2025; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; Issues related to improving strategies for early detection and prevention of Alzheimers; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151708,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"SWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5ad8f848-d4e0-4bdf-b014-99812a46595b/","filing_uuid":"5ad8f848-d4e0-4bdf-b014-99812a46595b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5ad8f848-d4e0-4bdf-b014-99812a46595b/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals","dt_posted":"2026-07-20T12:28:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12830 El Camino Real","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"San Diego","registrant_state":"CA","registrant_zip":"92130","registrant":{"id":401105828,"url":"https://lda.gov/api/v1/registrants/401105828/","house_registrant_id":null,"name":"ACADIA PHARMACEUTICALS","description":"Biopharmaceutical company","address_1":"12830 El Camino Real","address_2":"Suite 400","address_3":null,"address_4":null,"city":"San Diego","state":"CA","state_display":"California","zip":"92130","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL MATTOON","contact_telephone":"+1 615-861-6000","dt_updated":"2026-07-27T17:33:39.420897-04:00"},"client":{"id":207583,"url":"https://lda.gov/api/v1/clients/207583/","client_id":12,"name":"ACADIA PHARMACEUTICALS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"BINSA Act, H.R. 9102.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151391,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"TODD","last_name":"TELLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138768,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"MATTOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82d0e925-8f96-4e10-bb9b-ced64071378f/","filing_uuid":"82d0e925-8f96-4e10-bb9b-ced64071378f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82d0e925-8f96-4e10-bb9b-ced64071378f/print/","filing_document_content_type":"text/html","income":null,"expenses":"1800000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-07-20T12:42:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626/H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2026 (H.R. 9418) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2026 (H.R. 8060) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act of 2023 (S. 2287/H.R. 4425) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2762) Alleviating Barriers for Caregiving Act (S. 1227/H.R. 2491) Credit for Caring Act (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon INCLUDE Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (S. 1261/H.R. 4206) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Access to Timely Care Act of 2025 (S. 1816/H.R. 3514) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 6728) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1013) Catching Up Family Caregivers Act of 2026 (S. 4291/H.R. 8273) Improving Retirement Security for Family Caregivers Act of 2026 (S. 4291 /H.R. 8273) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565/H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Enhanced Alerts for Missing Loved Ones with Disabilities Act of 2026 (S. 4670/H.R. 9118) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood-based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to the reauthorization of the Alzheimers semipostal stamp Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"ALZHEIMERS IMPACT MOVEMENT (AIM)","url":"https://alzimpact.org","address_1":"655 15th Street, NW, Ste. 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/7ba229b3-435d-4ecd-a51a-018dfd969e12/","filing_uuid":"7ba229b3-435d-4ecd-a51a-018dfd969e12","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7ba229b3-435d-4ecd-a51a-018dfd969e12/print/","filing_document_content_type":"text/html","income":null,"expenses":"790000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tricia Brooks","dt_posted":"2026-07-20T12:58:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"200 Metro Boulevard","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Nutley","registrant_state":"NJ","registrant_zip":"07110","registrant":{"id":400321512,"url":"https://lda.gov/api/v1/registrants/400321512/","house_registrant_id":40258,"name":"EISAI INC.","description":"Pharmaceutical development, manufacturing and distribution -- Health Care","address_1":"200 Metro Boulevard","address_2":null,"address_3":null,"address_4":null,"city":"Nutley","state":"NJ","state_display":"New Jersey","zip":"07110","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TRICIA BROOKS","contact_telephone":"+1 202-934-3735","dt_updated":"2026-07-22T11:30:31.993646-04:00"},"client":{"id":189281,"url":"https://lda.gov/api/v1/clients/189281/","client_id":12,"name":"EISAI INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-28"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Pharmaceutical manufacturing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138282,"prefix":"ms","prefix_display":"MS.","first_name":"TRICIA","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146248,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146249,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"BROOKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}